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Summary 
Protein kinase B (PKB/Akt) belongs to a subfamily of serine/threonine protein kniases 
called AGC protein kinases. Homologues of PKB can be found in worms, flies and 
mammals. Three isoforms of PKB, termed PKBα/Akt1, PKBβ/Akt2 and PKBγ/Akt3 
that are encoded by three distinct genes, have been identified in mammals like mice 
and humans. 
PKB can be activated by numerous growth factors, hormones, cytokines and other 
stimuli through a phosphatidylinositol 3-kinase (PI3K)-dependent manner. The 
signaling pathway of PI3K/PKB/Akt has been established and the significance of this 
pathway for numerous cellular and physiological processes has been recognized and 
widely accepted.  
The understanding of developmental principles in mouse is a big challenge. How PKB 
contributes to mouse development and why three isoforms exist in mice have been 
wondering researchers in this field since the identification of these proteins in this 
animal.  
Early mouse work using northern blotting and in situ hybridization showed expression 
of PKB/Akt in mouse embryos with isoform- and tissue-specific properties. Thus, 
PKB/Akt may play important roles in mouse development. In addition, the distinct 
tissue distribution patterns of the three isoforms suggest that these proteins have 
different functions. 
To address these questions, we generated mouse mutant for each isoform by 
homologous recombination. Characterization and analyses of these mice have provided 
new insights into the functions of PKB/Akt in mouse development. We found that 
PKBα/Akt1 was the predominant isoform in placenta. PKBα/Akt1 mutant mice were 
born small with increased neonatal mortality. The mutant placenta displayed reduced 
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size and impaired development and glycogen-containing spongiotrophoblast cells are 
rare. More significant is a decrease in vascularization of the mutant placenta. As the 
size and structure of the placenta determines the growth of the fetus, we conclude that 
PKBα/Akt1 modulates placental development and, thus, fetal growth. 
In contrast to PKBα/Akt1 mutant mice, PKBγ/Akt3 mutant mice did not show 
increased postnatal mortality and and grew normally. However, these mice displayed a 
reduced brain size by 25% after birth. This indicates that PKBγ/Akt3 is an important 
modulator of postnatal brain growth. 
We crossed PKBα/Akt1 mutant mice with PKBγ/Akt3 mutant mice to produce 
compound knockout mice and found that the two proteins have different roles in the 
maintenance of animal survival. While Pkbα+/−Pkbγ −/− (Akt1+/-Akt3 -/-) mice survived 
normally, almost all Pkbα -/-Pkbγ +/-(Akt1-/- Akt3+/-) mice died at an early age with 
multiple pathologies. PKBα/γ (Akt1/3) double knockout mice were embryonic lethal at 
around E12. The development of these mice was severely impaired, including the 
branchial arch arteries, the brain and the placenta. We conclude that PKBα/Akt1 is 
more important than PKBγ/Akt3 for animal survival but both are required for mouse 
development.  
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Introduction 
 
1. Overview 
The main vertebrate model systems for current developmental research are the frog 
Xenopus, the chick, the zebrafish and the mouse. Compared with the other three 
vertebrates, the mouse has more similarities to humans in biochemistry, physiology, 
genetics and development. The almost complete mouse genome blueprint and the 
huge gene homology between the mice and humans (~90%) have greatly boosted 
our interest in this animal (Waterston et al., 2002). The knowledge obtained and our 
understanding of mice will have significant implications and an invaluable impact 
on human life. 
The study of mouse development has been facilitated extraordinarily by gene 
knockout techniques. The possible involvement of a gene in certain developmental 
events can be tested by its inactivation in mice. Meanwhile, unexpected phenotypes 
of various mutant mice have yielded a tremendous amount of knowledge about 
developmental processes and gene functions. In-depth understanding of early 
embryon development and organogenesis of mouse is accumulating faster than 
ever.=- 
In this section, the whole developmental process of the mouse embryo will be 
summeriz. I have a great personal interest in understanding the early events of 
mouse development. A comprehensive description of mouse embryogenesis and 
organogenesis will, I hope, lead us to the principles of mouse development. This 
becomes increasingly necessary for the study of knockout mice. 
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I will divide the development of the mouse in the uterus into two sections, 
embryonic development and extra-embryonic, i.e. placental development. 
Subsequently, PKB/Akt transgenic mice will be introduced. 
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2. Mouse development 
Mouse mating usually takes place at night. When the plug is found the next morning, it 
is recorded as 0.5 d.p.c (day post-coitum, or E0.5, embryonic day 0.5) meaning that 
fertilization is occurred half a day previously. A litter of pups is born in the morning of 
19.5 d.p.c. and traditionally, the gestation period in mice is considered to be 19.5 days 
(Figure 1). 
 
       Figure 1. The life cycle of the mouse (left). On the right from top to bottom,  
       a fertilized mouse egg, a mouse embryo of 8 d.p.c. (E8.0) and a mouse embryo of 
       14 d.p.c. (E14) (Modified from Wolpert et al., 1998)  
As shown in figure 1, embryogenesis and fetal growth from fertilization to birth can be 
divided into six stages, each one featuring one or more special events (Figure 1). The 
six stages include cleavage, implantation, gastrulation, turning, organogenesis, and 
fetal growth and development (Rossant and Tam, 2002; Wolpert et al., 1998). 
The egg is fertilized in the oviduct, where cleavage also occurs. The blastocyst is 
formed by 5 days after fertilization and the interaction between blastocyst and uterus 
starts implantation. Placentation, a developmental process of extra-embryonic tissues, 
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follows implantation (Rossant and Cross, 2001). In the embryo, the events of 
gastrulation, turning and organogenesis occur in parallel with placentation over a 
period of around 7 days. The remaining period of gestation is a time of overall growth 
of both placenta and embryo (Wolpert et al., 1998).  
Placenta is mainly an embryonic organ and the development and growth of the embryo 
are strongly dependent on placental function during gestation (Cross, 2000; Rossant 
and Cross, 2001). The development of the embryo and placenta will be described in 
two sections. 
2.1 Embryonic development 
2.1.1. Cleavage. It takes around 5 days from fertilization to the formation of the late 
blastocyst, during which the fertilized egg undergoes 5 cleavages to reach a solid ball 
of 32 cells called the morula (Loebel et al., 2003; O'Farrell et al., 2004).  The morula 
cells make a two-lineage commitment to form the early blastocyst, which continues 
development to the late blastocyst stage prior to implantation (Figure 2). 
 
 
 
 
 
Figure 2. Cleavage and development of the early blastocyst. The fertilized egg 
undergoes 5 cell cycles to reach the 32-cell morula. In the early blastocyst, there are 
 two cell lineages, trophoblast and inner cell mass. (Modified from Wolpert et al, 1998)  
In contrast to Xenopus and Drosophila, the early cell cycles following fertilization are 
not extraordinarily fast in mice (O'Farrell et al., 2004). In fact, the first cleavage takes 
as long as 1.5 days to reach the 2-cell stage. The next 4 cell cycles occur with an 
average of 12 hours each (2 days in total) to form the morula. The universal 32 cells 
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then differentiate into two groups, the trophoectoderm and the inner cell mass, giving a 
structure termed early blastocyst (Lu et al., 2001a; O'Farrell et al., 2004). During the 
following 24 hours, the inner cell mass becomes divided into two regions, the 
primitive endoderm and the epiblast; the trophoectoderm meanwhile gives rise to the 
polar and mural trophoectoderm (Bard, 1994; Wolpert et al., 1998). Finally, the late 
blastocyst is formed, consisting of around 120 cells (Figures 2, 3).  
2.1.2. Implantation. Interactions between the late blastocyst and the uterine wall 
trigger the mural trophectoderm to differentiate into trophoblast giant cells and the 
polar trophectoderm to form the ectoplacental cone (Figure 3). These are the initial 
events of placentation, which will be described in detail later.  
 
 
 
 
 
 
 
                 Figure 3. Early mouse embryogenesis. P→A, posterior to anterior. 
                   (Modified from Wolpert et al, 1998) 
The embryo proper develops only from the epiblast formed in the late blastocyst (Bard, 
1994; Wolpert et al., 1998). The rest of the blastocyst gives rise to the future placenta. 
Part of the epiblast, the later extra-embryonic mesoderm, also contributes to placental 
development (Figure 5) (Bard, 1994; Wolpert et al., 1998).  
Implantation is completed by E5.5 and the embryo joins the mother in the uterine wall 
like a bean bud spouting in the soil. The epiblast elongates and an internal cavity is 
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developed giving it a cup-shaped form (Figures 3, 4). The development of the embryo 
progresses to the egg cylinder (Figure 3) (Loebel et al., 2003; Lu et al., 2001a; Rossant 
and Tam, 2002; Wolpert et al., 1998). 
 
 
 
 
 
 
                    Figure 4. The formation of an internal cavity in the epiblast.  
                     (Modified from Wolpert et al, 1998)   
The cavity formation is possibly the first apoptotic event in mouse development. 
Originally, the epiblast is a solid structure of cells. During early embryogenesis, 
signals trigger the cells in the center to die creating a hollow structure (Figure 4). 
The cavity is filled with fluid (Wolpert et al., 1998). 
 
 
 
 
 
 
 
 
 
Figure 5. Cell lineage relationship, embryonic and extra-embryonic tissue origin in early 
mouse development. (Modified from Bard, 1994)  
Blastocyst
Trophectoderm
ICM
Mural trophectoderm
Polar trophectoderm
Primitive ectoderm
(epiblast)
Primitive endoderm
Primary giant cells
Secondary giant cells
Ectoplacental cone
Extra-embryonic ectoderm
Extra-embryonic mesoderm
Embryonic ectoderm
Embryonic mesoderm
Embryonic endoderm
Primordial germ cells
Allantois
Umbilical cord
Yolk sac
Blood stem cells
Visceral extra-embryonic endoderm
Visceral embryonic endoderm (displaced by definitive 
endoderm)
Parietal endoderm Reichert’s membrane
Chorio-
allantonic
placenta
 13
2.1.3. Gastrulation. Gastrulation starts at E6.5 with the formation of the primitive 
streak and the three germ layers, embryonic ectoderm, mesoderm and endoderm 
(Figures 3, 6-8). (Rossant and Tam, 2002; Wolpert et al., 1998) In the egg cylinder, 
there are two cell layers, the visceral endoderm and the epiblast. The epiblast is one 
curved (U-shaped) layer of epithelium. At a point of the posterior epiblast, cells 
proliferate and extend anteriorly to the bottom (tip) of the cylinder giving rise to 
multiple cell layers (Figures 3, 6-8). The proliferating epiblast cells migrate through 
the primitive streak laterally and anteriorly to form the layer or mesoderm between the 
ectoderm and visceral endoderm. In the end, three germ layers have formed (Figures 3, 
6-8) (Merrill et al., 2004; Rossant and Tam, 2002; Sun et al., 1999; Wolpert et al., 
1998). 
 
 
 
 
 
 
 
 
     Figure 6. Formation of the three germ layers. (Modified from Wolpert et al., 1998)  
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Figure 7. From egg cylinder to gastrulation. The primitive ectoderm (epiblast, in purple) 
develops into neural ectoderm. (Modified from Lu et al., 2001a)  
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     Figure 8. The primitive streak, the three germ layers in early embryos. 
     Abbreviations: ES, early streak stage; LS, later streak stage; EEX, embryonic/extra- 
     embryonic border; ENF/LNF, early/late neural-fold stage; (A) Anterior; (ac) amniotic 
     cavity; (al) allantois; (am) amnion; (bl) blood island; (ch) chorion; (Di) distal; (ec) 
     anterior ectoderm (prospective neuroectoderm); (ecc) ectoplacental cone; (em) embryonic 
     region; (en) endoderm; (ex) extraembryonic region; (exo) exocoelom; (fb) forebrain; (fg) 
     foregut; (hm) head mesoderm; (ht) heart; (mes) mesoderm; (nd) node; (ne) neuroectoderm; 
     (P) posterior; (Pr) proximal; (ps) primitive streak; (so) somite; (xe) extraembryonic 
     ectoderm; (xm) extraembryonic mesoderm. (Modified from Merrill et al., 2004 and Sun et 
     al., 1999) 
The primitive streak migrates towards the future anterior end of the embryo. Some 
cells condense at the embryo’s anterior end to form Hensen’s node (Figures 6- 8). 
Cells migrating anteriorly through the node will form the notochord. Somites develope 
bilaterally along the notochord. Both notochord and somite are derived from 
mesoderm (Merrill et al., 2004; Rossant and Tam, 2002; Sun et al., 1999; Wolpert et 
F
H
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al., 1998). The notochord is a transient structure and its cells are eventually 
incorporated into the embryo column. For example, the cells overlaying the notochord 
develop into the brain and spinal cord. The somites give rise to the vertebrae and ribs, 
to the muscles of the trunk and limbs, and also develop into the dermis of the skin 
(Table 1). 
At the late stage of gastrulation, some epiblast cells migrate through the mesoderm to 
enter the visceral endoderm and gradually replace it. This becomes the definite 
endoderm and develops into gut (Figure 9) (Bard, 1994; Sun et al., 1999; Wolpert et 
al., 1998).  
The three germ layers will contribute to different tissues late in development. The 
endoderm gives rise to the gut and its derivatives of the liver and the lungs; the 
mesoderm develops into the skeleton-muscular system, connective tissues, kidney, 
heart and blood; the ectoderm develops into epidermis and nervous system (Loebel et 
al., 2003; Wolpert et al., 1998). It should be emphasized that the mesenchyme is 
developed from the mesoderm (Kalluri and Neilson, 2003; Thiery, 2002). The 
mesenchyme in early embryo is the origin of a variety of cells in the connective 
tissues, such as astrocytes, adipocytes, chondrocytes, osteoblast, muscle cells and 
fibroblast (Kalluri and Neilson, 2003; Thiery, 2002). The transition from mesenchyme 
to connective tissue cells will be described in the section on epithelial-mesenchymal 
transition (EMT). 
 
Table 1. Tissue contribution of the three germ layers 
Germ layers Organs 
Endoderm gut, liver, lungs 
Mesoderm skeleton, muscle, kidney, heart, blood 
Ectoderm skin, nervous system 
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          Figure 9. Development of somites and gut. (Modified from Wolpert et al, 1998)   
2.1.4 Turning. During late gastrulation, the neural folds starts to form and primitive 
heart and liver also appear (Bard, 1994; Rossant and Tam, 2002; Wolpert et al., 1998). 
The embryo undergoes complicated folding and turning. The definite endoderm 
becomes internalized to form the gut, the heart and liver move to their final positions 
relative to the gut, and the head becomes distinct (Figure 10). The embryo turns to 
become entirely enclosed in the amnion and amniotic fluid. It is connected to the 
placenta by the umbilical cord (Figures 10 and 11) (Zoltewicz et al., 2004).  
 
 
 
 
 
Figure 10. Final embryo turning stage of gastrulation. The embryo has a distinct head 
and the branchial arch and forelimb buds start to develop. (Modified from Wolpert et al, 
1998)   
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2.1.5 Organogenesis. By the end of gastrulation, the embryo shows a distinct head and 
forelimb buds. The branchial arch, heart, liver and gut start to develop (Figure 11). The 
other organs form later (Bard, 1994; Rossant and Tam, 2002; Wolpert et al., 1998). At 
this stage, the majority of cell components in the embryo are various types of 
epithelium and mesenchymal cells. The epithelial-mesenchymal transition (EMT) is a 
major developmental event in the organogenesis of the heart and kidney (Kalluri and 
Neilson, 2003; Savagner, 2001; Thiery, 2002). This process will be described briefly 
here. The developmental events of nerulation, neural crest migration, and branchial 
arch formation are also explained because they are of great interest and are relevant to 
the phenotype revealed by the PKBα/γ (Akt1/3) double mutant mice. 
    Epithelial-mesenchymal transition (EMT) and its implications. After 
gastrulation, some mesoderm cells develop into a loose connective structure called 
mesenchyme, consisting of mesenchymal cells and extracellular matrix (Thiery, 2002). 
Mesenchymal cells can differentiate into a variety of cell types, including the 
astrocytes, adipocytes, chondrocytes, osteoblasts, muscles and fibroblasts in the 
connective tissue. During embryo development, the mesenchymal-epithelial transition 
Figure 11. Morphology of E 9.5 embryos. 
(Modified from Zoltewica et al., 2004) 
 19
(MET) and epithelial-mesenchymal transition (EMT) mediate cell differentiation and 
organogenesis (Figure 12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Mesenchymal cells can differentiate into many cell types through the MET 
and EMT. (Modified from Kalluri and Neilson, 2003)  
  
Usually, the primary mesenchymal cells originate from the mesoderm. Primary 
mesenchymal cells are reintroduced by MET into secondary epithelium that can 
differentiate into different types of cells via the EMT. The secondary epithelial cells in 
some organs can also be transformed into primary tumors that further undergo EMT to 
metastasize (Kalluri and Neilson, 2003; Thiery, 2002). Therefore, EMT is fundamental 
to both normal development and malignant transformation of epithelial cells. 
In the process of organogenesis of heart, kidney and pancreas, the EMT is essential for 
the generation of cardiac valves and septum, islet cells, nephric epithelium, and 
connective tissue (Reese et al., 2002). 
    Development of heart and its coronary vessels. The EMT in heart development 
occurs at E9.5. One day earlier at E8.5, the heart (heart tube) is composed of an outer 
layer of myocardium lined by a monolayer of specialized endothelial cells (Olson and 
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Schneider, 2003; Reese et al., 2002; Timmerman et al., 2004). The two layers are 
separated by a thick extracellular matrix of cardiac jelly that is secreted mainly by the 
myocardial cells. At E9.5, a subset of endocardial cells at the region of atrio-
ventricular canal (AVC) and outflow tract undergo an EMT to form the endocardial 
cushion, which will further develop into cardiac valves and septum (Figures 13-15). 
 
 
 
 
 
 
 
 
 
 
Figure 13. Heart development in mice. (cp) Cardiac progenitors; (hf) head folds; (ht) 
heart tube;(nt) neural tube; (ba) branchial arch; (ra) right atrium; (la) left atrium; (rv) 
right ventricle; (lv) left ventricle; (t) trabeculae. (Modified from Olson and Schneider, 
2003) 
 
 
 
Figure 14. E9.5 heart. (en) Endocardium; (at) atrium; (rv) right ventricle; (lv) left 
ventricle; (avc) atrio-ventricular canal; (mes) mesenchyme. (Modified from 
Timmerman et al., 2004)  
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EMT is also critical for coronary artery development (Reese et al., 2002). At E12.5, the 
newly formed epicardium, a simple squamous epithelium, completely envelops the 
heart. The cells then migrate and undergo EMT to form capillary plexi and smooth 
muscle, which are remodeled into definitive arteries. Eventually, the most proximal 
points of the major coronal arteries link up with the aorta (Figures 15,16) (Reese et al., 
2002). 
 
 
 
 
 
 
 
Figure 15. EMT and coronary artery development . PEO, proepicardial organ; (epi) 
epicardium; (myo) myocardium. (Modified from Reese et al., 2002)  
 
 
 
 
 
 
 
Figure 16. The coronary arteries. A. Two major arteries, the left and the right arteries can be 
seen on the anterior surface of heart. B. The posterior surface of the heart. (Modified from 
Reese et al., 2002)  
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    Neurulation and neural crest. As described above, the ectoderm is the origin of 
the central nervous system, including the brain and the spinal cord (Bard, 1994; 
Wolpert et al., 1998). At as early as E7.5, the ectoderm differentiates into the neuro-
epithelium of the headfold region to initiate the process of neurulation (Figures 7, 17, 
18) (Copp et al., 2003; Knecht and Bronner-Fraser, 2002; Sun et al., 1999). 
Neurulation is the embryonic process in which the neural plate, an epithelial structure 
developed from a specialized region of ectoderm on the dorsal surface of the embryo, 
undergoes shaping and folding to form the neural tube (Copp et al., 2003; Knecht and 
Bronner-Fraser, 2002; Wolpert et al., 1998). Neurulation accomplishes three major 
events in higher vertebrates: (1) It creates the neural tube, which gives rise to the 
central nervous system. (2) It creates the neural crest, which migrates away from the 
dorsal surface of the neural tube and gives rise to a diverse set of cell types. (3) It 
creates the bona fide epidermis, which covers the neural tube once it is created (Copp 
et al., 2003; Knecht and Bronner-Fraser, 2002; Wolpert et al., 1998). 
Neural crest cells originate from the edges of the neural folds and first become 
recognizable during neurulation (Figure 18). Later on, these cells undergo EMT and 
migrate away from the neural tube, giving rise to a wide variety of different cell types, 
including cartilage in the cranial-facial region of the head, pigment cells in the dermis, 
the medullary cells of the adrenal gland, glial Schwann cells, and the sensory neurons 
of both the peripheral and the autonomic nervous systems (Gammill and Bronner-
Fraser, 2003; Ghislain et al., 2003; Knecht and Bronner-Fraser, 2002; Trainor and 
Nieto, 2003). The cells remaining in the neural tube develop into the brain and spinal 
cord,i.e. the central nervous system. 
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 Figure 17. Neurulation and brain development. a-b, neurulation in more detail. At the 
bottom, different stages of brain development in humans is shown. The three parts of early 
brain are forebrain (proencephalon), midbrain (mesencephalon) and hindbrain 
(rhombencephalon). 
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Figure 18. Neural tube formation (neurulation) and neural crest cells. NC, neural crest 
cells. Right: A scanning electron micrograph of chick neural tube and early somites. (Modified 
from Gammill and Bronner-Fraser, 2003, Ghislain et al., 2003 and Wolpert et al., 1998)  
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Branchial arch and neural crest cells 
There are six bilaterally symmetric branchial arches (pharyngeal arches) in the mouse 
embryo, each of which gives rise to unique structures in the head and neck (Graham 
and Smith, 2001; Kaufman and Bard, 1999; Thomas et al., 1998). As mentioned 
above, the first branchial arch is distinct at around E9.0; the second arch is visible by 
E9.5 and the third, fourth and sixth branchial arches become apparent by E10 (Figures 
19,20) (Graham and Smith, 2001; Kaufman and Bard, 1999; Thomas et al., 1998). The 
branchial arches are epithelia-covered bars of mesenchyme developed from the neural 
crest cells. The mesenchyme later differentiates into specific organs and structures of 
the head and neck (Knecht and Bronner-Fraser, 2002; Thomas et al., 1998; Trainor and 
Nieto, 2003). A population of the mesenchymal cells, the cardiac neural crest cells, 
occupies the aortic arch arteries and are essential for remodeling the arch arteries 
(Knecht and Bronner-Fraser, 2002; Thomas et al., 1998; Trainor and Nieto, 2003) . 
The cardiac neural crest cells give rise to the entire musculoconnective tissue wall of 
the large arteries emerging from the heart, the membranous portion of the ventricular 
septum, and the septum between the aorta and pulmonary artery. In addition, these 
cells contribute to melanocytes, neurons, cartilage, and connective tissue of the third, 
fourth, and sixth branchial arches. The parathyroid, thyroid, and thymus glands 
develop from the branchial apparatus and also have a neural crest contribution (Figures 
19, 20) (Knecht and Bronner-Fraser, 2002; Thomas et al., 1998; Trainor and Nieto, 
2003). 
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   Figure 19. Migration of cardiac neural crest cells. (Modified from Bernadette C. 
Holdener, Dept.  of Biochemistry and Cell Biology, State University of New York at Stony 
Brook) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. Branchial arches and their arteries. A. The fate and development of branchial 
arch arteries (from early embryo to term).B. Sagittal section of E10.5 mouse embryo. C. 
Coronal section of mouse embryo. I, II, III, IV, branchial arches; 2a,3a, artery; 3p,4p pouch; 
DAo, dorsal aorta; (fg) foregut. (Modified from Liu et al., 2002 and Vitelli et al., 2002)  
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2.2 Extra-embryonic development----establishment of a functional placenta 
The placenta is a unique organ exclusive to mammals. It develops from the fertilized 
egg and is, therefore, an organ of the embryo (Alessi et al., 1996; Cross, 2000; Cross et 
al., 2002; Rossant and Cross, 2001; Rossant and Tam, 2002). However, it roots into the 
uterine wall of the mother similar to a tree into the soil, linking the fetus with the 
mother. During gestation, the development and growth of the fetus depends on the 
placenta for exchange of gases, nutrients and waste products between mother and 
baby. The placenta also produces pregnancy-associated hormones and growth factors 
and participates in the immune protection of the fetus. Any genetic or environmental 
alterations and insults affecting placental development or function may result in 
placental insufficiency and consequent impairment of fetal development and growth 
leading to growth retardation and malformation, even to death (Cross, 2000; Cross et 
al., 2002; Rossant and Cross, 2001; Rossant and Tam, 2002).  
 
 
 
 
 
 
 
 
 
 
 
     Figure 21. Vasculature and blood circulation in the placenta. (Modified from Adamson 
et al., 2002)  
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Placental development, placentation, is initiated from E3.5 and proceeds until E12.5. 
During this period, fetal development is rather slow. Subsequently, functional 
establishment of the placenta enormously improves the developmental conditions of 
the fetus and the increasing requirements for fetal growth are met. Fetal mass 
accumulates at an increasing rate. From E12.5 to 16.5, the placenta undergoes 
remodeling and growth together with the fetus.  
 
 
 
 
 
 
 
 
     Figure 22. Establishment of a functional placenta in mouse. (Modified from Rossant 
and Cross, 2001)  
2.2.1. Mouse placental development. As mentioned in the early embryo 
development, there are only two populations of cells in the early blastocyst, the inner 
cell mass (ICM) and the trophoblast, a mono-layer of epithelium (Figure 2). The inner 
cell mass will contribute mainly to the embryo proper, while the trophoblast develops 
into the greater part of the placenta (Rossant and Cross, 2001; Wolpert et al., 1998).  
In late blastocyst, a third population of cells appears, the primitive endoderm, and the 
trophoblast differentiates into the polar trophectoderm and mural trophectoderm  
(Figures 3 , 22) (Rossant and Cross, 2001; Wolpert et al., 1998). In development, the 
mural trophectoderm forms the primary trophoblast giant cells for implantation and the 
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polar trophectoderm the ectoplacental cone, a primitive placenta (Figures 3, 22). Later 
in gastrulation, some mesoderm cells give rise to the allantois and part of the chorion. 
Meanwhile, in the ectoplacental cone, the secondary trophoblast giant cells develop 
and the choriononic ectoderm is also formed (Rossant and Cross, 2001; Wolpert et al., 
1998). Thus, the chorion has two different origins, the mesoderm of the epiblast and 
the ectoderm of the ectoplacental cone (Figures 5, 7, 22). By E8.5, the allantois makes 
contact with the chorion, an event termed chorioallantoic fusion. After several hours of 
allantoic attachment, folds appear in the chorion where the fetal vascular network will 
be constructed (Rossant and Cross, 2001; Rossant and Tam, 2002). The trophoblast, 
together with its associated fetal blood vessels, subsequently undergoes extensive 
villous branching and remodeling to generate a densely packed structure, the labyrinth 
(Rossant and Cross, 2001; Rossant and Tam, 2002). At the same time, chorionic 
trophoblast cells begin to differentiate into the various layers of the trophoblast in the 
labyrinth (Figures 22, 24). 
2.2.2. Placental architecture. The mature placenta consists of three main layers, 
maternal decidua basalis (db), junction zone (jz) and labyrinth zone (lz) (Georgiades et 
al., 2001). Below is a schematic representative of a sagittal section of an E15.5 
placenta with the maternal side at the top and the fetal side at the bottom. The placenta 
is linked to the maternal uterine wall by the deciduas basalis. The labyrinth is a 
vascular network in which the fetal vessel capillaries are immersed in the maternal 
blood space (mbs) for nutrient, gas and waste product exchange. Some of the 
spongiotrophoblast (st) between the decidua basalis and the labyrinth synthesize 
glycogen (gc). The trophoblast giant cells line up between the spongiotrophoblast and 
the decidua basalis (tg). 
 30
 
 
 
 
 
 
 
 
     Figure 23. The architecture of the placenta. For abbreviations, see text. (Modified 
from Georgiades et al., 2001)  
 
2.2.3. The trophoblasts and the labyrinth. In early embryo development, the mural 
trophoectoderm gives rise to primary trophoblast giant cells for implantation (Rossant 
and Cross, 2001). In the mature placenta, the trophoblasts fall into four categories, the 
secondary trophoblast giant cells (tg in Figure 23), glycogen-containing 
spongiotrophoblast (gc in Figure 23), non-glycogen spongiotrophoblast (st in Figure 
23) and labyrinthine trophoblast (syncytiotrophoblast) (Georgiades et al., 2001). The 
secondary trophoblast giant cells and the spongiotrophoblast arise from the 
ectoplacental cone (Cross, 2000; Cross et al., 2002; Rossant and Cross, 2001), while 
all the other cell lineages in the placenta are derived from the epiblast (Lu et al., 2001a; 
Rossant and Cross, 2001). The functions of these trophoblasts are not completely clear. 
However, there is some evidence that the migration of trophoblast giant cells and 
spongiotrophoblasts are important for labyrinthine vascular expansion (Adamson et al., 
2002; Cross et al., 2002; Rossant and Cross, 2001). 
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The inset in Figure 23 shows a higher magnification of feto-maternal interface in the 
labyrinth. Between the fetal blood space (fbs) and the maternal blood space (mbs) is a 
trilayer structure of basement membrane (bm), fetal capillary endothelium (fce) and 
labyrinthine trophoblast (lt, also called syncytiotrophoblast). This structure is unique in 
that the syncytiotrophoblast lines the maternal blood space instead of endothelial cells 
in common vessels. These syncytiotrophoblasts synthesize alkaline phosphatase (AP) 
and can be visualized by AP staining. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24. Morphogenesis and signaling for establishment of the labyrinth.(Modified from 
Rossant and Cross, 2001)  
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Lessons learnt from knockout mice indicate that numerous transcription factors are 
indispensable for differentiation of trophoblast cells (Figure 25). 
 
 
 
 
 
 
 
Figure 25. Critical transcription factors for trophoblast differentiation with basic helix-
loop-helix (bHLH) transcription factors in black. (Modified from Cross 2000)  
 
2.2.4. Blood circulation in the placenta. The placenta is a highly vascular structure 
(Figure 22). The exchange of gases, nutrients and waste products is carried out by two 
systems of blood circulation, the maternal and the fetal (Adamson et al., 2002). 
Through the central maternal artery (cma), highly oxygenated maternal blood enters 
the labyrinth (maternal blood space, mbs) into which less oxygenated fetal blood flows 
(fetal blood space, fbs) through the artery of the umbilical cord. The two blood streams 
do not mix but separated by the feto-maternal interface and flow in opposite directions, 
as displayed in Figure 22. After exchange, blood returns to the mother and fetus by the 
maternal placental vein and the umbilical cord vein (Adamson et al., 2002). 
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3. Protein kinase B (PKB/Akt) and transgenic mice 
[Part of PHYSIOLOGICAL FUNCTIONS OF PKB/Akt (2004) Yang, et al. 
Biochemical society transactions, 32:350-354.] 
Introduction 
Three PKB/Akt isoforms have been identified in mice and humans (Brazil and 
Hemmings, 2001; Datta et al., 1999; Lawlor and Alessi, 2001; Scheid and Woodgett, 
2003) . These three PKB/Akt proteins, though encoded by distinct genes localized on 
different chromosomes, have ~80% amino acid identity and similar domain structures. 
Moreover, the differences between corresponding isoforms of humans and mice are 
subtle (2 to 10 in ~480 amino acids), which makes it feasible to determine the 
functions of PKB/Akt kinases in human physiology by studying them in the mouse. 
 
 
 
 
 
 
 
 
 
Figure 26. The three PKB isoforms in mouse. 
Stimulation by numerous growth factors, cytokines, hormones and neurotransmitters 
can activate PKB/Akt in a phosphatidylinositol 3-kinase (PI 3K)-dependent manner 
(Datta et al., 1999) and (Scheid and Woodgett, 2003). Through receptor tyrosine 
kinases, these stimuli cause PI3K activation, and generation of the membrane 
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phospholipid,  phosphatidylinositol 3,4,5-trisphosphate [PtdIns(3,4,5)P3]. 
PtdIns(3,4,5)P3 then recruits PKB/Akt to the membrane, where it becomes 
phosphorylated at threonine 308 and serine 473 (for  
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: MMTV-LTR, mouse mammary tumour virus-long terminal repeat; 
RIP, rat insulin promotor. Myr-PKB has Lck/Src myristylation signal sequence at the 
amino terminus for constitutive membrane attachment and activation(similar to gag-
PKB) and T308D/S473D is constitutively active. 
 
 
PKBα/Akt1) by two upstream kinases, PDK1 and an as yet to be identified Ser 473 
kinase. These processes of membrane targeting and activation of PKB/Akt can be 
facilitated and mimicked by adding the myristylation signal sequence of Lck/Src to the 
amino terminus of the PKB/Akt (Myr-PKB/Akt) or mutation of the two regulatory 
sites of PKB/Akt to acidic residues [PKB T308D/S473D (DD) in PKBα/Akt1](Alessi 
Table 2  A variety of PKB/Akt transgenic mouse models 
 
Targeting tissue Promoter PKB/Akt structure Reference 
Heart 
a-d) α-myosin heavy 
chain 
 
 
a) Myr-PKB-HA 
b) PKB (T308D/S473D) 
c) PKB (E40K) 
d) Myr-PKB 
(Condorelli et al., 
2002; Cook et al., 
2002; Matsui et al., 
2002; Shioi et al., 
2002) 
Thymus a,d) CD2 b,c) Lck 
a) gag-PKB 
b) HA-PKB; Myr-PKB-HA;  
    HA-PKBE40K 
c) Myr-PKB-HA 
d) Myr-HA-PKB 
(Jones et al., 2002; 
Jones et al., 2000; 
Malstrom et al., 
2001; Na et al., 
2003; Rathmell et 
al., 2003) 
Mammary gland a-d) MMTV-LTR  
a) HA-PKB (T308D/S473D) 
b) HA-Myr-PKB 
c,d) PKB 
(Ackler et al., 
2002; Hutchinson 
et al., 2001; 
Schwertfeger et al., 
2003; 
Schwertfeger et al., 
2001) 
Pancreas a,b) RIP a) Myr-PKB b) Myr-PKB∆4-     129 
(Bernal-Mizrachi 
et al., 2001; Tuttle 
et al., 2001a) 
Prostate Probasin Myr-HA-PKB (Majumder et al., 2003) 
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et al., 1996; Scheid and Woodgett, 2003). Myristylation of PKB/Akt promotes 
constitutive membrane attachment and activation, and the DD double mutant of PKB 
is constitutively active (Alessi et al., 1996; Scheid and Woodgett, 2003). Based on 
these facts, Myr-PKB/Akt and PKB T308D/S473D have been commonly used for 
vector construction to generate transgenic mice (Alessi et al., 1996) 
PKB/Akt transgenic mice 
A) Overexpression of PKB/Akt in tissues 
 The first PKB/Akt transgenic mouse model was reported in 2000 (Jones et al., 2000). 
Since then, more than 10 PKB/Akt transgenic mouse lines have been produced. 
Constructs of PKB/Akt and the tissues targeted are summarized in Table 2. At least 
two mouse lines were generated for the thymus, heart, pancreas and mammary glands. 
A single line has been generated for prostate. Tissue-specific promoters were used to 
drive overexpression of PKB/Akt in these different tissues. PKB/Akt was either 
myristylated for membrane targeting (activation), or mutated to double D 
(T308D/S473D) for constitutive activation. 
1) Hypertrophy and increased contractility with PKB/Akt overexpression in the 
heart 
The α-myosin heavy chain (α-MHC) promoter has been utilized extensively to drive 
transgenic expression exclusively in cardiac myocytes (Shioi et al., 2000). Three of the 
four PKB/Akt transgenic mouse lines directly use this promoter to drive PKB/Akt 
overexpression in the heart. In the fourth line, PKB/Akt transcription was under the 
control of a tetracycline-responsive promoter that reacts to α-MHC-directed 
expression of tetracycline controlled transactivator (t-TA) (Condorelli et al., 2002; 
Cook et al., 2002; Kovacic et al., 2003; Matsui et al., 2002; Shioi et al., 2002). The 
most apparent phenotype of these mice was sudden death of some founders with 
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massive cardiac dilatation (Matsui et al., 2002). Viable derived transgenic mouse lines 
showed cardiac hypertrophy, with around two-fold heart weight increase. The weight 
increase was associated with larger cardiac myocytes (Condorelli et al., 2002; Matsui 
et al., 2002; Shioi et al., 2002). These mice also showed a remarkable increase in 
cardiac contractility and reduction in infarct size after ischemia reperfusion compared 
with wild-type controls (Condorelli et al., 2002; Matsui et al., 2002). Overexpression 
of PKB/Akt in the heart also caused higher p70S6K phosphorylation, and reduced 
AMP-activated protein kinase (AMPK) activity (Kovacic et al., 2003; Matsui et al., 
2002; Shioi et al., 2002). The transcriptional effects of this chronic activation of 
PKB/Akt in the heart were analysed using DNA microarray to determine altered gene 
expression profiles. Of the differentially expressed genes, up-regulation of insulin-like 
growth factor-binding protein-5 (IGFBP-5) and down-regulation of peroxisome 
proliferator-activated receptor (PPAR)γ co-activator-1(PGC-1) and PPARα  suggest 
that these may have anti-apoptotic and survival  effects in the heart (Matsui et al., 
2002). Overall, these results demonstrate that PKB/Akt is an important modulator of 
heart growth. On the other hand, this also implies that sustained or increased PKB/Akt 
activity in the heart is one of the causes of cardiac hypertrophy under patho-
physiological conditions such as hypertension. 
2) Early onset of thymic lymphomas induced by overexpression of PKB/Akt in T 
cells 
The first reported PKB/Akt transgenic mouse line expressed a constitutively active 
form of PKB/Akt in T lymphocytes (Jones et al., 2000). Thereafter, two groups 
generated almost exactly the same mice to ask questions from different angles 
(Malstrom et al., 2001; Rathmell et al., 2003). Both groups reported the development 
of lymphomas at an early age and that the majority of the mice died between days 100 
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to 200. Tsichlis’ group was attempting to determine the mechanism of tumour 
induction by constitutively active PKB/Akt while Thompson’s group focused on the 
metabolic contributions by activation of PKB/Akt in T cells (Malstrom et al., 2001; 
Rathmell et al., 2003). 
In their Myr-PKB/Akt transgenic mice, Tsichlis’ group first observed, prior to tumour 
formation, that thymocytes were larger than in non-transgenic controls, although 
thymus size was the same because of fewer cells. Based on this, they hypothesized a 
thymic-intrinsic mechanism maintaining the size of the thymus by restriction of the 
cell proliferation driven by oncogenic Myr-PKB/Akt. Failure of this size regulation 
promotes cell proliferation and gives rise to an enlarged neoplastic thymus 
(lymphoma). To test this hypothesis, they isolated fresh thymocytes from transgenic 
and control thymus glands and found that the cell cycle profiles were not altered in 
transgenic thymocytes, which expressed low levels of cyclin D3. Nevertheless, once in 
culture, these transgenic thymocytes showed increases in both cell cycle progression 
and cyclin D3 levels, probably due to the release of thymic-intrinsic restriction 
mechanisms. Moreover, freshly isolated thymocytes from the lymphomas had higher 
levels of cyclin D3. These results supported their hypothesis for tumour induction in 
Myr-PKB/Akt thymus: constitutively active PKB/Akt can bypass the intrinsic size 
control mechanisms and cause tumorigenesis. This model of tumour development with 
increased PKB/Akt activity is intriguing and should help our understanding of the 
oncogenic functions of PKB/Akt. 
Other groups found that overexpression of PKB/Akt in T cells could influence positive 
and negative selection of thymocytes, survival, metabolism and activation/proliferation 
of T cells (Jones et al., 2002; Jones et al., 2000; Na et al., 2003; Rathmell et al., 2003). 
Furthermore, cross-talk was demonstrated between PKB/Akt and important TCR 
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downstream molecules modulating the threshold of thymocyte selection and T cell 
activation (Na et al., 2003). These observations are similar to the phenotypes displayed 
by Pten heterozygous mice, which have high PKB/Akt activity and develop auto-
immunity (production of nuclear antibodies and deposition of immune complexes in 
the glomerulus) and lymphomas, reinforcing the proposed role of PKB/Akt in 
tumorigenesis associated with the Pten muation (Suzuki et al., 1998). 
3) Fatty milk synthesis in the mammary gland with PKB/Akt overexpression 
PKB/Akt expression levels increase in the mammary gland during mouse pregnancy 
and more dramatically (12-fold) at the onset of lactation (Schwertfeger et al., 2003). 
This suggests important roles of PKB/Akt in mammary gland development and during 
lactation. After initiation of involution, the levels of PKB/Akt start to decrease and 
remain low during involution (Ackler et al., 2002; Hutchinson et al., 2001; 
Schwertfeger et al., 2003; Schwertfeger et al., 2001). Using the mouse mammary 
tumour virus (MMTV) promoter, three groups generated transgenic mice with 
PKB/Akt overexpression in the mammary gland. Initially, they all reported delayed 
involution of mammary glands in these mice (Ackler et al., 2002; Hutchinson et al., 
2001; Schwertfeger et al., 2003; Schwertfeger et al., 2001). Involution results from 
apoptosis of the epithelium in the mammary gland, overexpression of PKB/Akt could 
oppose this process by promoting epithelial cell survival (Ackler et al., 2002; 
Hutchinson et al., 2001; Schwertfeger et al., 2003; Schwertfeger et al., 2001). 
Intriguingly, a subsequent study of these mice found that females produced fatty milk 
with excess lipids (Schwertfeger et al., 2003). The fat content of milk from these 
lactating transgenic mice was as high as 65-70% by volume compared with the 25-
30% of wild-type mice. Overexpression of PKB/Akt in the mammary gland promoted 
synthesis of lipids in epithelial cells from early pregnancy until lactation. As a result of 
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lipid accumulation in the mammary gland, the milk was too viscous for sucking by the 
pups, and growth of the mice was retarded over the first 9 days of lactation. These 
findings suggest that PKB/Akt regulates lipid metabolism in the mammary gland 
(Schwertfeger et al., 2003). 
Tumour formation was not detected during a long period (over 1 year) of observation 
of the mammary glands of these mice (Hutchinson et al., 2001). Previous studies found 
a correlation between increased PKB/Akt activity and transformation in the mammary 
gland (Perez-Tenorio and Stal, 2002). Recent reports have confirmed this relationship 
by showing that PKB/Akt phosphorylated p27 on threonine 157, and that 
phosphorylated p27 relocated from the nucleus to the cytoplasm devoid of its growth 
inhibitory properties, thereby allowing breast cancer cell proliferation (Liang et al., 
2002; Shin et al., 2002; Viglietto et al., 2002). This discrepancy suggests that other 
mechanisms in combination with high PKB/Akt activity cause tumorigenesis in the 
mammary gland. 
4) Hypertrophy, hyperplasia and hyperinsulinemia of pancreas with PKB/Akt 
overexpression 
Overexpression of PKB/Akt in islet β cells of the pancreas driven by rat insulin II 
promoter (RIP) has been reported by two groups and both made similar observations 
(Bernal-Mizrachi et al., 2001; Tuttle et al., 2001b). “Three hypers of hypertrophy, 
hyperplasia and hyperinsulinemia” was the most suitable and concise description of 
these mice, as expressed in the title of one publication (Bernal-Mizrachi et al., 2001). 
Transgenic expression of PKB/Akt gave rise to larger islets in the pancreas due to both 
increased cell size and cell number. Therefore, it was concluded that high levels of 
PKB/Akt caused hypertrophy and hyperplasia of islets (Bernal-Mizrachi et al., 2001; 
Tuttle et al., 2001b). As a result of islet mass increase, insulin secretion was elevated 
 40
and these mice were resistant to streptozotocin-induced diabetes. However, the high 
levels of insulin in blood had little effect on the levels of glucose. These observations 
indicated that PKB/Akt activation could affect islet β cell mass by altering cell size 
and cell number and impact insulin production (Bernal-Mizrachi et al., 2001; Tuttle et 
al., 2001b). This implicates PKB/Akt in insulin action and diabetes, as discussed below 
(Cho et al., 2001a). Moreover, PKB/Akt could possibly be used to expand islet β cells 
for therapeutic purposes. 
5) Neoplasia induction by overexpression of PKB/Akt in the prostate 
A recent report added a new mouse line to the already long list of PKB/Akt transgenic 
mouse models (Majumder et al., 2003). This mouse strain showed PKB/Akt 
overexpression in the prostate initiated by a promoter from probasin, a specific protein 
expressed in the prostate. This latest mouse line provides new evidence that activation 
of PKB/Akt in epithelial cells can be oncogenic, and supports previous studies with 
Pten mutant mice. Pten mutant mice have elevated PKB/Akt activity, which is 
possibly responsible for prostate cancer development in these mice (Majumder et al., 
2003). Given the capability of PKB/Akt prostate transgenic mice to recapitulate human 
prostate cancer, it may be a useful model to study the role of PKB/Akt in prostate 
epithelial cell transformation, and to develop therapeutic strategies for this disease. 
B) PKB/Akt combination tumour models and others   
As mentioned above, chronic activation of PKB/Akt in mice failed to induce tumour 
formation in tissues such as pancreas and mammary gland, suggesting that activation 
of the PKB/Akt signaling pathway alone is not sufficient to initiate transformation in 
these tissues. It has become evident that malignant alteration involves a complex of 
signal transduction processes including multiple onco-proteins and tumour suppressors 
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such as Ras, Myc, PKB/Akt, Her-2/Neu, p53 and PTEN (Orsulic et al., 2002). 
Tumorigenesis results from synergistic interactions of these proteins. 
The first study of transformation by use of constitutively active PKB/Akt in 
combination with another oncoprotein was carried out by Holland and colleagues 
(Holland et al., 2000). They transferred active Ras and PKB/Akt to neural progenitors 
in mice and found that neither Ras nor PKB/Akt was able to cause glioblastoma 
multiforme (GBM) in the brain. Nevertheless, together they induced high-grade 
gliomas with features similar to human GBMs (Holland et al., 2000). Recent research 
results from Varmus’ group confirmed their observations (Orsulic et al., 2002). In a 
mouse model for ovarian carcinoma, even the combination of the three oncogenes c-
myc, K-ras and Pkb/Akt was insufficient to induce a tumorigenic state in wild-type p53 
mice. However, once introduced into p53-deficient mice, the addition of any two of the 
three oncogenes transformed cells (Orsulic et al., 2002). 
Other experiments performed in mice involved retroviral delivery of PKB/Akt to 
lungs, mesenchymal stem cells and femoral arteries (Kureishi et al., 2000; Lu et al., 
2001b; Mangi et al., 2003). Administration of PKB/Akt into vascular endothelial cells 
promoted angiogenesis (Kureishi et al., 2000), protected against oxidant-induced 
injury when introduced into the lung (Lu et al., 2001b), and prevented remodeling and 
restored the performance of infarcted hearts when delivered to stem cells (Mangi et al., 
2003). These studies have unveiled novel physiological functions of PKB/Akt, and 
illustrate the potential of PKB/Akt for gene therapy. 
To summarize these observations on transgenic mice with PKB/Akt overexpression in 
a variety of tissues and organs, it is obvious that PKB/Akt promotes both cell 
proliferation and cell growth apart from its anti-apoptotic properties. Depending on the 
structure and characteristics of the tissues, sustained high PKB/Akt activity alone 
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could be sufficient to cause transformation. Alternatively, it may contribute to tumour 
induction after integration with other effectors. 
4. The goal of this thesis 
 Nearly ten years’ PKB/Akt researcha has accumulated a large amount of knowledge 
on this kinase and unveiled some of its functions in cell biology. The findings that 
IGF1 and insulin can activate PKB/Akt have great implication of this kinase in growth 
control and insulin action. PKB/Akt was found amplified or over-activated in some 
human cancers, which together with its hallmark property of anti-apoptosis, suggests 
its important roles in animal survival and tumorigenesis. PKBβ/Akt2 mRNA is 
predominantly high in fat, liver and skeletal muscle implying its special involment and 
regulation in glucose metabolism and distinct function from the other two isoforms. 
The availability of gene knockout technology with mouse has made it possible to study 
PKB/Akt in mammals and the obtained knowledge will help understand the function of 
this kinase in humans. The long-term projects in the lab are generation of a variety of 
PKB/Akt mutant mice including single isoform knockout mice, double or triple 
knockout mice, to elucidate their contribution to development and physiology, and to 
use these mice as tools for future pharmaceutical and therapeutic studies.  
As a part of the long-term projects, the goal of this thesis is, 1) generation and 
characterization of Pkbα/Akt1 knockout mice; 2) elucidation of isoform-specific 
functions by comparison of the three single-isoform knockout mice; 3) in-depth 
understanding of PKB/Akt functions in double or triple knockout mice. 
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SUMMARY 
 
PKBα is implicated in the regulation of metabolism, transcription, cell survival, 
angiogenesis, cell migration, growth and tumorigenesis. Previously, it was 
reported that PKBα -deficient mice are small with increased neonatal mortality 
(Cho, H., Thorvaldsen, J.L., Chu, Q., Feng, F. and Birnbaum M.J. (2001). J. Biol. 
Chem. 276, 38349–38352. Chen, W.S., Xu, P.Z., Gottlob, K., Chen, M.L., Sokol, K., 
Shiyanova, T., Roninson, I., Wenig, W., Suzuki, R., Tobe, K., Kadowaki, T. and 
Hay, N. (2001). Genes Dev. 15, 2203–2208). Here we show that PKBα is widely 
expressed in placenta including all types of trophoblast and vascular endothelial 
cells. Pkbα -/- placentae display significant hypotrophy, with marked reduction of 
the decidual basalis and nearly complete loss of glycogen-containing cells in the 
spongiotrophoblast, and exhibit decreased vascularization. Pkbα -/- placentae also 
show significant reduction of phosphorylation of PKB and endothelial nitric oxide 
synthase (eNOS). These defects may cause placental insufficiency, fetal growth 
impairment and neonatal mortality.  These data represent the first evidence for 
the role of PKBα and eNOS in regulating placental development and provide an 
animal model for intrauterine growth retardation.  
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INTRODUCTION 
Animal size is determined by combination of cellular processes that control cell 
number (proliferation), cell size (mass) and cell death, including apoptosis (Conlon and 
Raff, 1999). Multiple genetic modifiers are involved in this process during fetal 
development and post-natal growth (Han and Carter, 2001; Okada and Kopchick, 
2001). Hormones and growth factors play an important role in growth control. Among 
them insulin, insulin-like growth factor 1 (IGF-1)1, and insulin-like growth factor 2 
(IGF-2) activate the phosphoinositide 3-kinase (PI3K) signaling pathway (Blume-
Jensen and Hunter, 2001; Han and Carter, 2001; Okada and Kopchick, 2001; Prada 
and Tsang, 1998). Recent evidence indicates that many downstream events of PI3K 
signaling are mediated by the serine/threonine protein kinase B (PKB, also known as 
Akt) (Brazil and Hemmings, 2001; Datta et al., 1999).  
In mammals, there are three known PKB isoforms: PKBα/Akt-1, PKBβ/Akt-2 and 
PKBγ/Akt-3 encoded by separate genes. These proteins have a similar domain 
structure with about 80% amino acid identity (Brazil and Hemmings, 2001). PKB 
promotes or inhibits many cellular and physiological processes through 
phosphorylation of numerous substrates. Around 30 – 40 proteins are phosphorylated 
by PKB. These proteins are involved in glucose metabolism, transcription, cell cycle 
regulation, survival, inflammation, and angiogenesis. Overexpression of PKBα/Akt-1 
in mouse pancreatic β cells substantially increased both cell size and total islet mass 
(Bernal-Mizrachi et al., 2001; Tuttle et al., 2001b). A second transgenic mouse model 
specifically expressing constitutively active PKBα in the heart, displayed a 2-fold 
increase in heart size with an increase in cardio-myocyte cell size (Matsui et al., 2002; 
Shioi et al., 2002). In a mouse model for ovarian carcinoma, expression of any two of 
the three oncogenes c-myc, K-ras, and Pkbα is sufficient to induce ovarian tumor 
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formation in a p53-deficient background (Orsulic et al., 2002). These animal models 
indicate that increased PKBα activity promotes both cell growth and proliferation. 
To study the physiological roles of PKB, we generated PKBα−deficient mice by 
targeted gene disruption. We found that inactivation of PKBα caused hypotrophy and 
structural abnormalities of the placenta that probably contribute to placental 
insufficiency and subsequent impairment of fetal growth. Our results suggest a novel 
role for PKBα in the regulation of placental development and fetal growth. 
 
FOOTNOTES 
 
1 The abbreviations used are: IGF-1 and 2, insulin-like growth factor 1 and 2; PI3K, 
phosphoinositide 3-kinase; PKB, protein kinase B; Q-PCR, quantitative real time PCR; 
ICM, inner cell mass; ES, embryonic stem cells; VEGF, vascular endothelial growth 
factor; TSC 1 and 2, Tuberous sclerosis complex 1 and 2; S6K, ribosomal protein S6 
kinase; GSK3, glycogen synthase kinase 3; eNOS, endothelial nitric oxide synthase; L-
NAME, N(G)-nitro-L-arginine methyl ester; IUGR, intrauterine growth retardation. 
2 Z-z. Yang, O. Tschopp and B.A. Hemmings, unpublished data. 
 
3 O. Tschopp. D. Brodbeck. Z-z.Yang and B.A.Hemmings, unpublished data 
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EXPERIMENTAL PROCEDURES 
Total RNA Isolation and Quantitative Real Time PCR (Q-PCR) 
Total RNA was extracted and purified using Trizol Reagent (Invitrogen) and RNeasy 
96 kit (Qiagen). Primer pairs and FAM/TAMRA-labeled TaqMan probes for real time 
PCR were designed using the Primer Express v 2.0 program (ABI PRISM, PE 
Biosystems). For the Q-PCR reaction, 50ng total RNA was mixed with 5' and 3' 
primers (T-forward, the sequences are, for α, 5’-GGCAGGAAGAAGAGACGATGG-
3; for β, 5’-GAGGACGCCATGGATTACAAG-3’; for γ, 5’-
CAGAGGCAAGAGGAGGAGAG-G-3’ and T-reverse, the sequences are: α, 5’-
CCATCTCTTCAGCCCCTGAG-3’; β, 5’-GACAGCTACCTCCATCATCTCAGA-
3’; γ, 5’-TGTAGACGCATCCATCTCTTCTT 
C-3’; 10 µM each), Taqman probe (the sequences are; α 5’-CTTCCGATCA-
GGCTCACCCAGTGACA-3’; β, 5’-TGGCTCCCCCAGTGACTCTTCCAC-3’; γ, 5’-
TGAATTGTAGCCCAACCTCACAG-ATTGATAATATAGG-3’; 5 µM each), 
MuLV reverse transcriptase (6.25 units, PE Biosystems), RNase inhibitor (10 units, 
Invitrogen) and the components of the TaqMan PCR reagent kit (Eurogentec) in a total 
volume of 25 µl following the TaqMan PCR reagent kit protocol (Eurogentec). 
Reverse transcription and real time PCR was performed in a GeneAmp Sequence 
Detector 5700 (PE Biosystems) as follows: 2 min reverse transcription at 50°C, 10 min 
denaturation at 95°C followed by 50 cycles of denaturation for 15 sec at 95°C and 
annealing and elongation for 1 min at 60°C. The relative quantitation of gene 
expression was calculated as described in the ABI PRISM 7700 user bulletin #2 (PE 
Biosystems). 
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Mouse Pkbα Gene Disruption 
We isolated one positive clone from 129/SvJ BAC genomic library (Genome 
Systems Inc.) using a mouse Pkbα cDNA probe and subcloned three BamHI fragments 
of 6.5 kb, 2.8 kb and 10 kb, and a 5kb XbaI fragment containing all 14 exons. These 
subcloned fragments were completely sequenced and assembled. To construct the 
Pkbα targeting vector, we generated a 1.9 kb left-arm using PCR and fused it in frame 
to the 5.5 kb of lacZ/Neo. A 6.7 kb right-arm was ligated to the 3’ end of the Neo 
cassette and the whole fragment was subcloned to pBluescript KS– (Stratagene). The 
linearized vector (SalI) was introduced into 129/Ola ES cells and G418 resistant clones 
(96) were analyzed for homologous recombination using PCR. The primers were: (a) 
P684265-2, 5’-CCCACGACAGAAAGTTGTGCG-3’ (b) LacZ-2, 5’-
CGTCTGGCCTTCCTGTAGCC-AG-3’. Positives clones (5) were further 
characterized by Southern blot. Two male chimeras gave germ-line transmission. The 
progeny from Pkbα +/- intercrossing have 129/Ola and C57BL/6 mixed background. 
Mice with a 129/Ola/Sv background were also generated. Genotyping of progeny was 
done by multiplex PCR with the following three primers: (a) Pkbα 5’, 5’-
AGACTCTGAGCATCATCCCTGGG-3’; (b) LacZ-2 (sequence as above); (c) Pkbα 
3’, 5’-TGAAGCAGGCCTAGAGCCCCATG-3’.  
 
Western Blot Analysis 
Tissues lysates were prepared by homogenization in lysis buffer (50 mM 
Tris·HCl, pH 8.0; 120 mM NaCl; 1% NP-40; 40 mM β-glycero-phosphate; 100 µM 
Na3VO4; 1 µM Microcystin LR). Tissue debris was removed by centrifugation at 
13000 rpm for 10 min at 4 oC. Protein concentrations were determined using the 
Bradford assay. Protein (50 µg) was fractionated by 10% SDS-PAGE and transferred 
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to Immobilon-P PVDF membrane. A polyclonal antibody against PKBα was obtained 
by immunizing rabbits with a peptide corresponding to the last 14 amino acids of 
human PKBα (Jones et al., 1991). The peptide sequence for generation of mouse 
PKBα specific antibody was VADGLKRQEEETMDFRSGSPSDNSGA. Antibodies 
for phospho-PKB (Ser473), p70S6K and phospho-p70S6K, GSK3 and phospho-GSK3, 
phospho-TSC2 and phospho-eNOS were purchased from Cell Signaling Technologies. 
eNOS antibody was purchased from BD Transduction Laboratories. 
 
Histological Studies 
Placentae and organs from adult mice were dissected and fixed in formalin 
solution (10% v/v) overnight at 4°C, then processed as follows, 30 minutes in PBS at 
4°C; 30 minutes in 0.85% NaCl (in H2O) at room temperature; 2 x 20 minutes in 50% 
ethanol (in 0.85% NaCl) at room temperature; 2 x 20 minutes in 70% ethanol (in PBS) 
at room temperature. The samples were then embedded in paraffin. Sections (5 and 10 
µm) were stained with haematoxylin and eosin. Genotype of embryos was determined 
by PCR as above using DNA from yolk sac or from embryonic tissues. For 
immunohistochemistry, placentae from overnight formalin fixation were embedded in 
carbowax (OCT compound, Tissue Tek), cryosectioned at 20 µm, and treated with 
methanol for 30 minutes to inactivate endogenous peroxidase at room temperature. 
Sections were blocked for 30 minutes in 5% normal goat serum in PBS, and then 
incubated overnight at 4oC with PKB antibody. The sections were then processed as 
described in the protocol from Vectastain ABC kit (Vector Laboratories). For alkaline 
phosphatase (AP) staining, 20µm cryosections were bathed in PBS for 10 minutes at 
room temperature, and then incubated with AP color reagents A and B (Bio-RAD). 
Periodic acid Schiff’s staining was performed with paraffin sections. 
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Measurement of Fetal Vessels in Placenta 
Digital pictures of wild-type and mutant placentae were taken under similar 
conditions with a Nikon digital camera (Nikon D1X). Vessel area and total vessel 
length in each placenta were measured with Image-Pro Plus software. The data were 
then processed for statistical analysis. The results are presented as arbitrary units. 
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RESULTS 
Expression of PKB Isoforms in Mouse Tissues  
The expression profile of the mRNA encoding the three PKB isoforms was determined 
by quantitative PCR using total RNA obtained from 3 male and 3 female wild-type 
mice. For this comparative analysis, the level of PKBα in the brain was set at 100% 
and all other tissues were compared to this value for each isoform (Fig.1.1A). PKBα 
was expressed in all organs and tissues examined but the levels in pancreas and 
skeletal muscle was very low. However, in most tissues and organs, PKBβ levels were 
the highest and PKBγ levels were the lowest. Notably, PKBβ mRNA was highly 
abundant in the insulin-responsive tissues such as fat, skeletal muscle and liver as 
previously reported (Altomare et al., 1998b; Cho et al., 2001a). PKBγ levels were high 
in the brain and testis, lung, mammary gland and fat, but were extremely low in other 
tissues. The amount of PKBα protein was also investigated by Western blot with an 
isoform-specific antibody (Fig.1.1B). PKBα protein was most abundant in brain, 
thymus and testis, with slightly lower levels observed in heart, lung, pancreas, spleen, 
and fat. Significantly, the lowest levels of PKBα protein were found in skeletal 
muscle, liver, and kidney. Similar results were obtained with a second α-specific 
antibody directed against residues 106-131 of mouse PKBα2. There were marked 
differences between the mRNA and protein levels of PKBα in some tissues, which 
may be due to mRNA translation differences and/or protein turnover. 
Pkbα Gene Structure and Disruption 
We sequenced approximately 24 kb of the mouse Pkbα locus that contains 13 coding 
exons (Bellacosa et al., 1993) and found a non-coding exon (termed exon 0) and the 
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promoter region of the gene (Fig. 1.2A). In order to ablate the Pkbα gene, a targeting 
vector (Fig. 1.2B) was  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.1. mRNA expression profiles of PKB isoforms and Western blot analysis of the 
α isoform.  
A, Quantitative PCR analysis of mRNA encoding the three PKB isoforms from wild-type 
mice. We dissected 16 organs and tissues from three wild-type males and three wild-type 
females for total RNA isolation. Results are expressed as the mean ± SD. The results were 
normalized using pre-developed TaqMan assay reagents for detection of human 18S rRNA as 
an internal control. B, Western blot analysis of PKBα from wild-type mouse tissues. The 
experiment was repeated with three wild-type mice and gave similar results. 
 
constructed by insertion of a lacZ/Neo cassette into exon 1 to replace its coding 
segment, which encodes the first 15 N-terminal amino acids, thereby disrupting its 
transcriptional organization (Leitges et al., 2001). Correctly targeted embryonic stem 
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cell clones were identified using a PCR-based strategy (Fig. 1.2C). One of the clones 
possessing the correctly targeted allele was used for blastocyst aggregation, and germ-
line transmission was achieved. Heterozygous (Pkbα +/-) mice were mated to produce  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.2.  Pkbα gene disruption.  
A, Structure of the Pkbα gene. The translation start codon ATG is indicated by an arrow, 
coding exons are numbered from 1 to 13 and exon 0 is a non-coding exon. B, Schematic 
representation of the mouse Pkbα allele (top), targeting vector (middle) and targeted allele 
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(bottom). A LacZ/Neo cassette was introduced at the start ATG in exon 1 to disrupt translation. 
B indicates BamHI. P1 (P684265-2) and P2 (lacZ-2) are two primers used for ES clone 
screening by PCR. SA 1.9 was used as a probe for Southern analysis. C, PCR screening for 
positive clones. The amplified product is ~2.2 kb. D, Southern blot analysis of the progeny of a 
Pkbα +/- intercross. The wild-type band is 5.3 kb and the targeted band is 4.5 kb (SstI 
digestion). E, PCR genotyping of progeny. The wild-type and targeted bands are 300 and 220 
bp, respectively. F, Western blot analysis of the PKBα protein in Pkbα +/+, Pkbα +/- and  Pkbα -
/- mice. Protein extracts were prepared from heart and lysates from HEK293 cells transfected 
with HA-tagged mouse PKBα was used as a positive control.  
 
homozygous (Pkbα -/-) offspring that were genotyped by PCR and characterized by 
Southern analysis (Fig. 1.2D and E). Western blot analysis using an isoform specific 
antibody, confirmed the absence of PKBα protein (Fig. 1.2F). Using several different 
PKB antibodies we did not find any evidence for truncated protein products in heart, 
thymus and spleen confirming that our targeted disruption strategy led to a null 
phenotype (data not shown) 
These mice have 129/Ola and C57BL/6 mixed genetic background. The phenotype 
described in this article is similar between mice with the 129/Ola/Sv or 
129/Ola/C57BL/6 mixed background. 
Increased Neonatal Morbidity and Mortality with Pkbα -/- Mice 
We genotyped by PCR approximately 600 pups from Pkbα +/- intercrosses at 2–4 
weeks after birth. The percentage of Pkbα -/- offspring obtained was ~ 17% (Table 1.1), 
indicating that about 40% of Pkbα -/- mice were already lost. Therefore, embryos were 
isolated at different stages of gestation and genotyped using PCR. The number of Pkbα 
-/- embryos from embryonic ages of E14 to E18 was consistent with the expected 
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Mendelian ratio, excluding early embryonic lethality as a cause of decreased Pkbα -/- 
progeny (Table 1.1). Pkbα -/- intercrosses (homozygous intercrosses) revealed that 
Pkbα -/- mice were fertile, but produced markedly smaller litters compared to Pkbα +/- 
intercrosses (6.7 ± 2.5, n=40, vs. 9.7 ± 3.3, n=40, respectively; p<0.01). Furthermore,  
Table 1.1   
Frequency of progeny from Pkbα +/- intercrosses 
Male and female of Pkbα +/- were mated for a short time (4 hours). Plugging 
was checked at the end of mating and was determined as E0. 
Genotype Stage 
Pkbα +/+ Pkbα +/- Pkbα -/- 
Total 
Number 
E14 23 (21%) 58 (53%) 29 (26%) 110 
E15 26 (21%) 69 (54%) 32 (25%) 127 
E16 39 (32%) 62 (51%) 21 (17%) 122 
E17 20 (21%) 53 (56%) 22 (23%) 95 
E18 23 (28%) 36 (45%) 22 (27%) 81 
2-4 weeks 166 (28%) 323 (55%) 100 (17%) 589 
 
increased mortality, mainly within the first 3 days after birth, was observed in litters 
generated from Pkbα -/- intercrosses (62 of 268 mice, 23.1%) compared to litters from 
Pkbα +/- intercrosses (30 from 389 mice, 7.7%). Pkbα -/- newborns appeared small, 
weak and pale and frequently the majority of pups from Pkbα -/- intercross litters died 
within 10 days. The precise cause of death was not determined. Intercrosses of Pkbα +/- 
males with Pkbα -/- females revealed an intermediate phenotype in terms of litter size at 
birth (7.5 ± 2, n=22) and postnatal mortality of the pups (18 from 166 mice, 10.8%).  
Pkbα -/- Mice Exhibit Reduced Body Weight and Delayed Growth  
At birth, Pkbα -/- mice (from heterozygous intercrosses) were distinguishable from 
their wild-type littermates by their smaller size (see Supplementary figure). The body 
weight of mutant newborns was approximately 70% of wild-type littermates (body 
weight: wild-type, 1.49 ± 0.16 g, n=15, vs. mutant, 1.1 ± 0.11 g, n=12, p<0.01). 
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Surviving Pkbα -/- mice grew slowly after birth, and some of these mice were 
extremely stunted and lean. One litter of mice (11 pups) from a Pkbα +/- intercross was 
observed from birth until 13 months of age. The growth curve indicated that Pkbα -/-  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary figure. Post-natal growth retardation of Pkbα -/- mice.  
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A, Mean body weight of wild-type and Pkbα -/-newborns. 15 wild-type and 12 Pkbα -/-
newborns from 5 litters were weighed (* p<0.01). B, Pkbα +/- and Pkbα -/- pups from one litter 
at 5 days after birth. C, Representative growth curve of wild-type and Pkbα -/-littermates from 
birth to adulthood. D, Representative picture of wild-type and Pkbα -/-littermates at 20 days 
after birth. E, F, Growth curves of wild-type and Pkbα -/- littermates from 2 to 13 months old. 
E, male; F, female. 
 
mice maintained their small size from birth to adulthood. At 13 months, two Pkbα -/- 
males weighed 32.5 g and 32.7 g, respectively, while a wild-type male littermate 
weighed 48.5 g; one Pkbα -/- female and one wild-type female littermate weighed 26 g 
and 34.1 g, respectively.  
The major organs and tissues, including brain, heart, liver, spleen, thymus, skin, bone 
marrow, pancreas, testis, ovary, lung, kidney, fat, skeletal muscle, and stomach, from 5 
wild-type and 5 Pkbα -/- mice (2 males and 3 females of each genotype) were dissected 
and examined at 2 months of age. Organ weight reduction, with the exception of the 
brain and pancreas, in Pkbα -/- mice was proportional to the body weight reduction. 
Histological examination did not reveal any major difference between wild-type and 
Pkbα -/- mice apart from a modest reduction in the subcutaneous fat in the Pkbα -/- 
mice2. In addition, biochemical examination of metabolites, enzymes and electrolytes 
did not reveal any significant difference between wild-type and Pkbα -/- mice2.  
Placental Hypotrophy and Fetal Growth Impairment in Pkba -/- Mutant Mice 
Following dissection of E14.5 embryos, we found that the mutant embryos were 20% 
smaller than their wild-type littermates (embryo weight: wild-type, 291 ± 45 mg, n=15; 
Pkbα -/-, 235 ± 49 mg, n=12, p<0.01; Fig. 1.3A). In addition, we found that the 
placental weight of mutant embryos was 24% lower than that of wild-type littermates 
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(placenta weight at E14.5: wild-type, 121 ± 18 mg, n=15; Pkbα -/-, 92 ± 17 mg, n=12; 
p<0.01; Fig. 1.3A).  Macroscopically, the placentae from mutant embryos were not 
only small but also thin. These differences were also observed at later embryonic 
stages: at E16.5 the weight of wild-type embryos was 707 ± 86 mg (n=16) and that of 
mutants 586 ± 67  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.3. Placental hypotrophy and fetal growth impairment of Pkbα -/- mice. 
A, Reduced size of E14.5 Pkbα -/- embryos and their placentae. Embryos and their placentae 
were dissected from Pkbα +/- intercrosses at E14.5. After weighing the embryos and placentae, 
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tissues from the embryos or yolk sac were dissected and used for DNA isolation and 
genotyping by PCR. Data from wild-type and Pkbα -/- embryos and placentae were collected 
for statistical analysis as shown in the left (* p<0.01). The right picture shows the smaller size 
of Pkbα -/- embryo and its placenta compared to those of wild-type at this gestational age. B, 
Similar results were obtained at E16.5 (left, weight of wild-type and Pkbα -/- embryos and 
placentae,* p<0.01; right, picture of wild-type and Pkbα -/- embryos and placentae at this age.) 
 
mg (n=12) (Pkbα -/- /wild-type=83%; p<0.01; Fig. 1.4B); the weight of wild-type and 
mutant placentae was 142 ± 18 mg (n=16) and 94 ± 17 mg (n=12), respectively (Pkbα 
-/- /wild-type=66%. p<0.01, Fig. 3B). From E14.5 to E16.5, the wild-type placentae 
increased in weight (mean weight from 121 mg to 142 mg) while the weight of mutant 
placentae did not change (mean weight from 92 mg to 94 mg). It thus appears that the 
growth and development of both mutant placenta and embryo were impaired.  
Altered Development of Pkbα Mutant Placentae  
Next, we performed histological analysis to study the structure of wild-type and 
mutant placentae. Haematoxylin and eosin staining showed that all three major layers 
of placenta, decidua, spongiotrophoblast and labyrinth, were smaller in mutant 
placentae compared to the wild-type (Fig. 1.4A). In addition, the decidua was 
disproportionately decreased or apparently missing in some mutant placentae 
(Fig.1.4A). Periodic acid Schiff’s staining showed a marked reduction of glycogen-
containing cells in the spongiotrophoblast in mutant placentae (Fig.1.4B and C).  We 
also performed alkaline phosphatase staining to display these cells in order to study 
fetal vascular structure. We found that the outline of labyrinth was easily discerned 
after staining and observed that fetal vasculature was disordered with fewer vessels 
(Fig.1.4D to F). 
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Expression and Subcellular Distribution of PKBα in Placentae  
Disruption of the Pkbα gene apparently causes severe hypotrophy and developmental 
changes of placenta, suggesting that PKBα is required for normal placental 
development. To test this, we first examined the protein levels of PKBα in placenta 
compared to brain where its levels are high. Western blot with a PKBα specific 
antibody showed that, in three wild-type placentae from one litter of E14.5 embryos, 
the amount of PKBα was similar and significantly higher than that in brain (Fig.1.5A). 
We performed immunhistochemical staining with a PKBα specific antibody to study 
its localization in E14.5 wild-type placenta. The results show that PKBα was present 
in all types of trophoblast cells and vessel endothelial cells except in the decidua where  
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Fig. 1. 4. Structural abnormalities of E14 mutant placentae.  
A, Haematoxylin and eosin staining shows that in mutant placenta, the major layers of decidua, 
spongiotrophoblast and labyrinth were reduced but the decrease of decidua was more 
significant than other layers. Magnification: 20X. De, decidua. B, Periodic acid Schiff’s 
staining shows a marked reduction of glycogen-containing cells in the spongiotrophoblast in 
mutant placentae. Magnification: 20X. C, Higher magnification of B, 40X. Bracket indicates 
the glycogen-containing cells in the spongiotrophoblast. D to F, Structure of the labyrinth 
revealed by alkaline phosphatase staining. D, The outline of the labyrinth is clearly shown 
(blue color). Note that the vasculature is disordered in mutant 1. Magnification: 20X. E, 
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Higher magnification of D, 40X. Fetal erythrocytes are stained brown in the blood vessels. 
Note that in mutant 1, fetal blood vessels were dilated and the total blood vessel area was 
greatly reduced. Mutant 2 shows reduced and disordered vasculature. F, Higher magnification 
(100X) of labyrinth. 
 
the amount was relatively low. In contrast, with mutant placenta we could not detect 
any PKBα (Fig. 1.5B to D). This was consistent with the immunoblot analysis that 
revealed an absence of PKBα from mutant placenta from heterozygous intercrosses 
(Fig. 1.5E). In this type of mating, the decidua in the mutant mice was derived from 
the Pkbα +/- maternal uterus (whereas the other parts of the placenta are derived solely 
from the embyo). Indeed we also set up matings between homozygous males and 
females and collected data for placentae and embryos. We found that placentae and 
embryos from homozygous matings were smaller than those from heterozygous 
matings (data not shown). This suggests that the genotype of the mother contributes to 
the phenotype.  
  
Significant Reduction of Phosphorylation of PKB and eNOS in Mutant Placentae 
with Decreased Vascularization 
The status of the other two PKB isoforms, β and γ from wild-type placenta was 
analyzed by Western blot using isoform-specific antibodies. We found that both were 
expressed in mature wild-type placenta, with no apparent up-regulation in mutant 
placenta at the protein level2. Furthermore, we analyzed the phosphorylation levels of 
PKB using an antibody specific for the hydrophobic motif phosphorylation site 
(Ser473 in PKBα) that recognizes all three phosphorylated isoforms. Three wild-type 
and three mutant placentae from one litter were examined for this purpose. We found  
 63
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig  1.5. Immunohistochemical and Western analysis of PKBα in placenta.  
A, Western blot analysis of wild-type E14.5 placenta and whole adult brain lysates for PKBα. 
B to D, Immunohistochemical analysis of placental PKBα. B, PKBα is detected in all 
placental cells types except decidua but is absent in mutant placenta. Magnification: 20 X. De, 
decidua. C, Higher magnification of B: 40 X. D, Arrowheads indicate the endothelium of fetal 
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capillaries on the left and trophoblast giant cells on the right. MBS, maternal blood space. E, 
Western blot analysis of genotyped placenta obtained from a Pkbα +/- intercross. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. 6. Phospho Western blot analysis of PKB, eNOS, TSC2 and p70S6K of placentae.  
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A, Placentae from 3 wild-type and 3 mutant littermates were analyzed for phosphorylation 
status of proteins involved in PKB signaling with the indicated antibodies. An actin blot is 
included as a loading control. B, Quantitation of the Western blot signals. The sum of the 
relative absorbance intensities for the three samples was compared for the wild-type and Pkbα 
-/- placentae.  
 
that the phosphorylation levels of PKB at Ser473 in all three mutant placentae were 
reduced markedly (84% decrease) compared with wild-type indicating that PKBα 
represents the major phosphorylated (active) isoform in placenta (Fig. 1.6A and B). 
Phosphorylation levels of tuberous sclerosis complex 2 (TSC2) and p70S6K were 
slightly increased in mutant placentae compared with wild-type (Fig. 1.6A). However, 
the phosphorylation status of eNOS phosphorylation on Ser1177, were substantially 
reduced (59% decrease) in mutant placentae (Fig. 1.6A and B). Because eNOS 
phosphorylation by PKB is important for angiogenesis (Kurieishi et al., 2000), we 
analyzed the vasculature on the fetal side of placenta from E14.5 wild-type and mutant 
embryos. Microscopically, we found that in mutant placentae there were significantly 
less blood vessels and the vessels were smaller and shorter compared to wild-type. The 
vascular branching was scarce and the micro-vessel covering area was also markedly 
decreased in mutant placentae (Fig. 1.7A). To compare the difference quantitatively, 
digital pictures of placentae were taken and used to measure the vessels with image-
processing software. Two parameters were measured to analyze the vascularization of 
wild-type and mutant placentae: total visible vessel length and the vessel-covering area. 
In total, we examined 5 mutant and 11 wild-type placentae from 5 litters of embryos of 
heterozygous crosses. The results revealed significant differences between wild-type 
and mutant placenta (total vessel length per placenta: mutant, 894 ± 654; wild-type,  
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Fig. 1.7. Reduced vascularization in Pkbα -/- placentae 
A, A representative picture showing vascular decrease of a mutant placenta. B, Quatitation of 
vessel length and vessel area in mutant placenta (* p< 0.05 for vessel length and * p< 0.01 for 
vessel area). 
 
1848 ± 817, [mutant/wild-type=48%] p<0.05; vessel-covering area per placenta: 
mutant, 84912 ± 41131; wild-type, 163846 ± 26264 [mutant/wild-type=52%] p<0.01 
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Fig. 1.7B). The percentage decrease of total vessel length (52%) and vessel-covering 
area (48%) was greater than that of weight reduction of the placenta (29%). Thus, the 
vascular decrease is more severe than the weight reduction. 
DISCUSSION 
Our results suggest that PKBα is a major component of the signal transduction 
apparatus responsible for placental development and fetal growth in mice. Loss of 
PKBα results in a marked reduction of total phosphorylation levels of PKB leading to 
a defect in the growth and development of placenta and suggest that fetal growth 
retardation of PKBα null mice is apparently due to defects in placental function and 
subsequent insufficiency. The results also suggest that the β and γ isoforms of PKB 
can only partially compensate for the loss of the α. 
In early mouse embryo development, the differentiation of trophoblast into 
trophectoderm parallels the formation of the inner cell mass (ICM) in the blastocyst by 
E3.5. The ICM gives rise to the embryo itself plus extra-embryonic membranes, such 
as the allantois and the amnion, while the trophectoderm develops into the 
ectoplacental cone, which eventually becomes the placenta (Ihle, 2000; Rossant and 
Cross, 2001). PKBα can be detected in murine ES cells derived from the ICM (Rathjen 
and Rathjen, 2001; Williams et al., 2000)2. This indicates that PKBα may also be 
expressed in trophoblasts during early embryogenesis. Our findings that PKBα is 
highly expressed in the mature placenta with widespread distribution in all type of 
trophoblast cells reinforce this possibility. Coincidentally, both IGF-1 and IGF-2 are 
expressed during early embryogenesis (Lopez et al., 1996; van Kleffens et al., 1998) 
and suggests that the insulin/IGF/PI3K/PKB-signaling pathway may function at this 
stage of embryonic development promoting mitosis, differentiation, and cell growth. 
Recently, Kamei et al. reported that the PI3K/PKB signaling pathway regulates the 
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development of the differentiated trophoblast giant cell phenotype using trophoblast 
stem cell lines (Kamei et al., 2002).  
PKBβ knockout mice are insulin-resistant and display diabetes mellitus-like symptoms 
indicating that PKBβ is essential for glucose metabolism and insulin signal 
transduction, but apparently does not affect fetal growth (Cho et al., 2001a). Pkbγ gene 
has been also successfully targeted in our lab and the size of these mice is normal3. 
Overall, these results reinforce the important and distinct role of PKBα in placental 
development and fetal growth control. Although the levels of PKBβ and γ are low 
compared with that of α, all three are necessary for placental function since decrease 
of γ levels together with absence of α (Pkbα -/- γ +/-) intensify the small phenotype of 
placenta and embryo, and Pkbα/γ double knockout mice  (Pkbα -/-γ  -/-) are embryonic 
lethal2. This raises the possibility that the growth retardation of PKBα null mice is a 
combination of placental insufficiency and autonomous fetal growth impairment. The 
observation that the mutant mice sustain their small size during life suggests that 
growth retardation may be imprinted. To test this hypothesis tetraploid rescue 
experiments need to be performed. Generation of mice with placenta-specific (extra-
embryonic tissue-specific) knockout of PKBα will also help address this question. 
PKB has been well documented as a key mediator of cell and organ growth in 
Drosophila and mouse (Leevers et al., 1996a; Stocker et al., 2002; Tuttle et al., 2001b; 
Verdu et al., 1999a). Recently, the protein product of the tumor suppressor gene TSC2 
was identified as substrate of PKB implicated in regulating p70S6K activity (Gao et 
al., 2002; Inoki et al., 2002; Potter et al., 2002). PKB phosphorylates TSC2 and 
promotes disassembly of the TSC1-TSC2 complex relieving the inhibition of p70S6K. 
Therefore, we checked whether the PKB-TSC2-p70S6K pathway was altered in 
mutant placenta where total PKB phosphorylation was very low. Adamson and Cross 
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found that placental growth continues until E17.5 (Adamson et al., 2002) and our 
results are consistent with these observations (wild-type placental weight increased 
from 121 ± 18 mg at E14.5 to 142 ± 18 mg at E16.5). Based on this, we speculate that 
the growth control pathway of PKB-TSC2-p70S6K may be required in placenta during 
this period. However, when we analyzed the phosphorylation levels of TSC2 and 
p70S6K in E14.5 placentae, we could not find any significant difference between wild-
type and mutants.  
During placental development, extensive angiogenesis and vascularization take place 
to form new blood vessels, which then dilate and become modified (Cross et al., 2002; 
Rossant and Cross, 2001). In mature placenta, maternal and fetal vascular structures 
are interconnected to ensure efficient nutrient and gas exchange between mother and 
fetus (Adamson et al., 2002; Cross, 2000; Rossant and Cross, 2001).  These facts 
prompted us to examine the VEGF-PKB-eNOS signaling pathway. Our results 
demonstrate that there was no change in the level of transcripts encoding VEGF (data 
not shown) and in the protein levels of eNOS in mutant placenta. However, when we 
evaluated the phosphorylation of eNOS on Ser1177, we found significant reduction of 
eNOS phosphorylation in mutant placenta. As phosphorylation of eNOS at this site is 
important for its activation (Dimmeler et al., 1999; Fulton et al., 1999), reduced 
phosphorylation may result in decreased activity of this enzyme in mutant placenta.  
The cellular and physiological effects of eNOS activation by PKB have been 
demonstrated recently using mouse and rabbit endothelial cells (Hafezi-Moghadam et 
al., 2002; Luo et al., 2000; Rossant and Cross, 2001; Scotland et al., 2002). First, 
eNOS phosphorylation on Ser-1177 by PKB is required for endothelial cell migration 
induced by VEGF, and is also important for basal and stimulated NO release in both 
endothelial cells and in intact blood vessels. Second, delivery of constitutively active 
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PKB to rabbit femoral arteries significantly promote new vessel formation, increased 
the resting diameter and blood flow while L-NAME, an eNOS inhibitor, blocked this 
vasodilatation. In contrast, endothelium-dependent vasodilatation in response to 
acetylcholine is reduced in vessels transfected with dominant-negative PKB (Luo et 
al., 2000; Scotland et al., 2002). Third, corticosteroids improve vasorelaxation and 
blood flow and thus generate acute and rapid cardiovascular and stroke protective 
effects, through PI3K/PKB signaling-dependent activation of eNOS (Kurieishi et al., 
2000; Limbourg et al., 2002). Thus, these results demonstrate that the PKB-dependent 
activation of eNOS is important and necessary for endothelial survival, new vessel 
formation, vasorelaxation and dilatation, and blood flow.  Therefore, it is reasonable to 
attribute the phenotype of Pkbα mutant placenta to the reduced eNOS activity. The 
decreased angiogenesis, vasodilatation and blood flow restrict the growth and 
development of Pkbα mutant placenta. Indeed, mice with eNOS disruption display not 
only hypertension but also abnormal prenatal and postnatal development including 
placental hypotrophy, fetal growth restriction and reduced survival (Hefler et al., 
2001). 
Another significant result obtained in this study was the nearly complete loss of 
glycogen-containing spongiotrophoblast cells in mutant placenta. This result is 
consistent with the role of PKB in regulating GSK3 and indirectly glycogen synthase. 
Decrease of PKBα would lead to constitutive activation of GSK3 and therefore inhibit 
glycogen synthesis. Coincidentally, mice lacking eNOS also show insulin resistance 
and decreased insulin-stimulated glucose uptake which indicates that eNOS is 
important for the control not only of arterial pressure but also of glucose and lipid 
homeostasis (Duplain et al., 2001). 
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Intrauterine growth retardation (IUGR) is a major problem affecting infant mortality 
and morbidity, accounting for about 8% of human pregnancies (Anthony et al., 2001; 
Regnault et al., 2002). The etiologies for IUGR are complicated and are frequently 
associated with abnormalities in placental growth, structure and function (Pardi et al., 
2002; Regnault et al., 2002). These abnormalities adversely affect placental function, 
and restrict the nutrient supply to the fetus, eventually giving rise to slow growth. The 
phenotypes of Pkbα -/- mice are strongly reminiscent of human IUGR. The 
mechanisms responsible for IUGR at the molecular level are still not clear. The results 
from the PKBα deficient mouse implicate PKBα-eNOS signaling inefficiency as one 
of the possible causes of this condition. 
In conclusion, our studies have confirmed and extended two previous reports on the 
phenotype of PKBα knockout mice (Chen et al., 2001; Cho et al., 2001b), and 
provides novel insights into the function of PKBα in placental development and fetal 
growth. The results demonstrate a major role for PKBα in regulating mouse embryo 
development, probably mediated by insulin, IGF-1 and IGF-2. Significantly, our 
findings reinforce the significance of PKB-eNOS signaling in placentation. Loss of 
PKBα also profoundly affects postnatal growth. This study also provides novel 
insights into the understanding of human IUGR, and may have applications for the 
development of therapeutic approaches for this condition.  
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Abstract 
Protein kinase B (PKB /Akt) is implicated in many critical cellular processes such 
as metabolism, cell proliferation, survival and apoptosis. Three closely related 
isoforms have been identified and termed PKBα/Akt1, PKBβ/Akt2 and 
PKBγ/Akt3. To elucidate the physiological role of PKBγ mice with targeted 
disruption were generated. In contrast to PKBα-deficient mice, Pkbγ -/- mice are 
viable and do not present a growth retardation syndrome. In adult Pkbγ mutant 
mice, the brain size and weight were dramatically reduced by about 25%. MRI 
analysis of Pkbγ -/- brains revealed a uniformly reduced size, affecting all major 
brain regions. Histological analysis of Pkbγ  -/- brains displayed smaller structures, 
but a structurally unaltered organisation. The reduced brain weight of Pkbγ -/- 
mice is caused, at least partially, by a significant reduction of the cell size and cell 
number. Our results provide novel insights into the function of PKBγ and suggest 
a critical role in the postnatal brain development. 
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Introduction 
Protein kinase B (PKB, also named Akt) is a second messenger-regulated kinase, 
which has been implicated in many critical cellular processes such as glucose 
metabolism, cell proliferation, apoptosis and angiogenesis (Brazil and Hemmings, 
2001). In mammalian cells, three closely related isoforms of the PKB family have been 
identified and termed PKBα/Akt1, PKBβ/Akt2 and PKBγ/Akt3 (Brodbeck et al., 1999; 
Cheng et al., 1992; Jones et al., 1991; Masure et al., 1999; Nakatani et al., 1999). 
These proteins are products of three separate genes located on distinct chromosomes 
and are broadly expressed, but with some isoform-specific features, e.g. PKBβ is 
expressed at high levels in insulin-sensitive tissues (Altomare et al., 1998a; Yang et al., 
2003) . All three members of the PKB family contain a highly conserved amino-
terminal pleckstrin homology (PH) domain, a central catalytic domain and a short 
carboxy-terminal regulatory domain (Brazil and Hemmings, 2001). In addition, a 
minor C-terminal splice variant lacking the hydrophobic motif of PKBγ was identified 
(Brodbeck et al., 2001).  
PKB is activated by a large set of stimuli, including growth factors, hormones and 
cytokines (Brazil and Hemmings, 2001; Datta et al., 1999). Activation of PKB occurs 
in response to signaling via phosphoinositide 3-kinase (PI-3K) and requires the 
membrane-bound second messenger phosphatidylinositol-3,4,5-triphosphate (PIP3) 
(Burgering and Coffer, 1995; Cross et al., 1995). The current model for PKB 
regulation proposes that PIP3, generated following PI-3K activation, interacts with the 
PH domain of PKB, recruiting the kinase to the plasma membrane and promoting a 
conformational change that allows phosphorylation. Phosphorylation occurs on two 
regulatory sites by upstream kinases on the plasma membrane. One of these critical 
phosphorylation sites resides in the activation loop of the kinase domain (Thr-308 in 
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PKBα) and the other is located in the C-terminal regulatory domain (Ser-473 in 
PKBα) (Alessi et al., 1996; Brodbeck et al., 1999; Meier et al., 1997). The recent 
results describing the crystal structure of the inactive and active forms of PKBβ have 
revealed a novel mechanism for the regulation of PKB by hydrophobic motif 
phosphorylation (Yang et al., 2002a; Yang et al., 2002b).  
The upstream kinase which phosphorylates Thr-308 in the activation loop of the kinase 
domain of PKBα in a PIP3-dependent-manner has been identified and termed 3-
phosphoinositide-dependent kinase-1 (PDK-1) (Vanhaesebroeck and Alessi, 2000). 
Thr-308 phosphorylation is necessary and sufficient for PKB activation; however, 
maximal activation requires additional phosphorylation at Ser-473 by a kinase that has 
been characterized biochemically but the molecular identity of which remains 
undetermined (Alessi et al., 1997; Hill et al., 2002). Recently, a negative regulator of 
PKB was identified and termed carboxy-terminal modulator protein (CTMP). CTMP 
inhibits the phosphorylation of PKB and thus blocks downstream signaling (Maira et 
al., 2001).  
PKB was shown to phosphorylate numerous substrates involved in the regulation of 
cell metabolism, survival and growth such as glycogen synthase kinase-3 (GSK3), 
Forkhead transcription factor and caspases (Brazil and Hemmings, 2001; Datta et al., 
1999).  
All three PKB isoforms are implicated in tumor formation (Nicholson and Anderson, 
2002). The Pkbα gene is amplified in human gastric cancer and displays an increased 
activity in breast and prostate cancer (Staal, 1987). PKBβ has been over-expressed in 
ovarian, pancreatic and colon tumors (Cheng et al., 1992). Upregulation of PKBγ has 
been found in estrogen-receptor negative breast tumor and in androgen-insensitive 
prostate cancer cell lines (Nakatani et al., 1999). 
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Recently, mice with targeted disruption of Pkbα, Pkbβ or both genes were obtained. 
Pkbα mutant mice display an approximately 30% reduction of body size and a partial 
neonatal lethality (Chen et al., 2001; Cho et al., 2001b; Yang et al., 2003). Moreover, 
loss of Pkbα led to a placental hypotrophy with impaired vascularization (Yang et al., 
2003). Glucose metabolism was not altered in Pkbα -/- mice. In contrast, Pkbβ 
deficient mice exhibit a diabetes-like syndrome with elevated fasting plasma glucose, 
hepatic glucose output and peripheral insulin resistance, but only mild growth 
retardation syndrome (Cho et al., 2001a; Garofalo et al., 2003). Furthermore, the 
adipose tissue mass was significantly reduced (Garofalo et al., 2003).  Mice lacking 
both isoforms die after birth, probably due to respiratory failure (Peng et al., 2003). 
Additionally, Pkb α/β double mutant newborns display a severe body weight reduction 
(≈50%) and a prominent atrophy of the skin and skeletal muscle, as well as an 
impaired adipogenesis and a delayed ossification.  
In this article, we report the generation and characterization of mice with targeted 
disruption of the Pkbγ gene. In contrast to Pkbα -/- mice, Pkbγ mutant mice are viable 
without an increased perinatal mortality and do not display a growth retardation 
syndrome. Loss of PKBγ profoundly affects the postnatal brain growth. Brains from 
adult Pkbγ mutant mice show a dramatic reduction of size and weight, affecting all 
major parts of the brain. Taken together, our results suggest a novel and important role 
of PKBγ in postnatal brain development.
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Methods 
Targeted disruption of the PKBγ gene by homologous recombination 
A ~11 kb Hind III fragment was subcloned which contain Pkbγ exon 4 and 5. An Nco I 
site was generated into exon 4 for insertion of a ~5 kb IRES-LacZ-Neo cassette. The 
targeting vector was linearized with Sal I and electroporated into 129/Ola ES cells. An 
external probe was used for ES cell screening following Xba I digestion. An internal 
probe and a LacZ-Neo probe were used for characterization of ES clones positive for 
homologous recombination (data not shown). Correctly targeted ES cells were used to 
generate chimeras. Male chimeras were mated with wild type C57BL/6 females to 
obtain Pkbγ +/- mice, which were intercrossed to produce Pkbγ homozygous mutants. 
The progeny from Pkbγ +/- intercrosses have a mixed genetic background of 129/Ola 
and C57BL/6. Genotyping of progeny was done 3-4 weeks after birth by multiple PCR 
with the following three primers: (a) Pkbγ 5’, GGTTCTGTGGGAGGTAGTTCTC; (b) 
New-neo-2, GCAATCCATCTTGTTCAATGGCCG; and (c) Pkbγ 3’, 
CCATCGGTCGGCTACGGCTTGG.  
Animals 
Mice were housed according the Swiss Animal Protection Ordinance in groups with 12 
h dark-light cycles and with free access to food and water. All procedures were 
conducted under relevant authority approval.  
Quantitative real time PCR  
The levels of PKB isoforms in wildtype and mutant mice were determined by Q-RT-
PCR. The experiment was performed as previously described (Yang et al., 2003). 
Briefly, total RNA was purified using Trizol Reagent (Invitrogen). For the Q-PCR 
reaction, 50 ng total RNA was mixed with 5' and 3' primers, Taqman probe, MuLV 
reverse transcriptase, RNase inhibitor and the components of the TaqMan PCR reagent 
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kit (Eurogentec) in a total volume of 25 µl following the TaqMan PCR reagent kit 
protocol.   
Western blot analysis 
For Western blot analysis, protein lysates were prepared by homogenization of various 
organs in lysis buffer (50 mM Tris-HCl, pH 8.0; 120 mM NaCl; 1% NP-40; 40 mM β-
glycero-phosphate; 100 µM Na3VO4; 1 µM Microcystin LR). Homo-genates were 
centrifuged twice (13000 rpm for 10 min at 4 oC) to remove cell debris. Protein 
concentrations were determined using the Bradford assay. Protein (50 µg per sample) 
was separated by 10% SDS-PAGE and transferred to Immobilon-P PVDF membrane 
(Millipore). PKB isoform specific antibodies were obtained by immunizing rabbits 
with isoform specific peptides as previously described (Yang et al., 2003). To purify 
antibodies, sera were preabsorbed on membranes loaded with protein lysates from 
Pkbγ -/- mice. Antibodies against phospho-PKB (Ser473), phospho-GSK-
3α/β (Ser21/9) phospho-TSC2 (Thr1462) and phospho-p70S6K were purchased from 
Cell Signaling Technologies. Antibodies against p27 and ERK were purchased from 
Santa Cruz Biotechnology. Antibody against phospho-ERK (Thr202/Tyr204) was 
purchased from Promega. Pan actin antibody was purchased from NeoMarkers. 
Histological examination 
For histological analysis, animals were perfused with phosphate-buffered saline and 
4% paraformaldehyde in phosphate-buffered saline. Organs were dissected and kept in 
the same fixation solution overnight at 4 oC. Samples were embedded in paraffin 
following dehydration in ethanol. Tissues were cut in 6 µm thick sections and stored 
for staining. For hematoxylin-eosin (company) and cresyl-violet (Sigma) stainings, 
sections were deparaffinazed and stained as previously described (Yang et al., 2003). 
For immunohistochemistry, brains were fixed as described above, kept in sucrose 
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solution overnight, embedded in carbowax (O.C.T. compound, Tissue Tek) and 20 µm 
sections were prepared. Sections were blocked for 30 minutes in 5% normal goat 
serum in phosphate-buffered saline and then incubated overnight at 4 oC with the 
primary antibodies. The sections were subsequently processed according to the 
manufacturers` protocol from Vectastain ABC kit (Vector Laboratories).  
Cell number determination 
To determine the number of cells in a whole brain, the DNA content was determined 
as described by Labarca and Paigen (Labarca and Paigen, 1980). Briefly, the method is 
based on the enhancement of fluorescence seen after binding of Bisbenzimid (Riedel-
de Haen) to DNA. A linear standard curve (1 µg/ml to 10 µg/ml) was determined to 
calculate the DNA concentration (data not shown). 
Magnetic resonance imaging (MRI)  
Adult PKBγ wild type and mutant mice (n=5 per group, female 4 months old) 
underwent MRI examinations at 2.35 T using a MRBR 4.7/400 mm magnet (Magnex 
Scientific, Abingdon, England) equipped with BGA20 gradients (100 mT m 1) driven 
by a DBX system (Bruker Biospin, Ettlingen, Germany). For in vivo studies the 
animals were treated as previously described (Natt et al., 2002). Subsequently, mice 
were perfused as described and brains were analysed histologically. 
Statistical analysis 
To compare body weight, brain weight and volume, brain/body weight ratio, DNA 
content and cell number between Pkbγ +/+ and Pkbγ -/-, an unpaired Students t-test was 
performed. P-values below 0.05 were considered as significant and p-values below 
0.01 as highly significant. 
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Results 
Targeting strategy and confirmation of genotype 
Pkbγ -/- mice were generated by targeted disruption of exon 4 thereby abolishing  
protein translation (Fig.2.1 A). The ablation of PKBγ was confirmed by PCR, Q-RT-
PCR and Western blot analysis using brain tissue samples from Pkbγ wild type, 
heterozygous and mutant mice (Fig.2.1 B and C). To confirm the absence of PKBγ, 
Western blot analysis was performed with an isoform specific anti-PKBγ antibody. In 
contrast to the Pkbγ+/+ brain tissue samples, we did not find a detectable level of PKBγ 
in the samples derived from mutant mice (Fig.2.1 C). Furthermore, quantitative RT- 
PCR displayed a complete ablation of the PKBγ mRNA in brain samples of Pkbγ 
mutant mice (data not shown). Additionally, Western blot analysis with antibodies 
specific for PKBα and PKBβ, respectively  did not reveal a compensatory upregulation 
of PKBα and/or PKBβ in the brain of Pkbγ -/- mice (Fig.2.1 D).  
Distribution of PKBγ in various wild type tissues 
It has been reported that the PKBα and β isoforms are broadly expressed among all 
organs, but with some isoform specific features (Yang et al., 2003 Altomare et al., 
1998). Less is known about the tissue distribution of the PKBγ isoform. Previous 
reports suggest, that the PKBγ isoform has a more restricted pattern, with high levels in 
the adult brain and fetal heart and low levels in liver or skeletal muscle (Brodbeck et 
al., 1999; Yang et al., 2003; Masure et al., 1999). Therefore, the tissue distribution of 
PKBγ was assessed by quantitative RT-PCR and Western blot analysis, respectively, in 
15 major tissues. The mRNA levels of PKBγ were normalized to the level of PKBγ in 
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the brain. PKBγ mRNA was found at highest levels in brain and testis and at lower 
levels in lung, mammary gland, fat and spleen (Fig.2.2 A).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Targeting strategy and confirmation of genotype 
(A) The genomic organization of the Pkbγ wild type allele (top) was disrupted using a 
targeting vector with an IRES-LacZ-Neo-cassette (middle). Targeting of the wild type allele 
leads to the disruption of exon 4 of the Pkbγ gene (bottom). Arrowheads indicate the 
localization of the primers for the PCR reaction. 
(B) The genotype of mice was confirmed using a PCR-based strategy. A representative result 
from Pkbγ +/+ (≈500bp), Pkbγ+/- and Pkbγ -/- (≈350 bp) mice are shown.  
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(C) The level of PKBγ in the brain of Pkbγ +/+, Pkbγ+/- and Pkbγ -/- mice, respectively, was 
determined by Western blot analysis using a PKBγ specific antibody (50 µg protein per lane).  
(D) The levels of PKBα and PKBβ, respectively, were determined in brain lysates from Pkbγ 
+/+, Pkbγ+/- and Pkbγ -/- mice, respectively, using PKBα or PKBβ specific antibodies (50 µg 
protein per lane). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 2 Tissue distribution of PKBγ and levels of PKBα and β in PKBγ mutant  mice 
(A) The mRNA level of PKBγ was determined in 15 different organs from PKBγ +/+ mice. 
Total RNA was isolated from 3 adult mice and the levels were normalized to the level of PKBγ 
in the brain (100%).  
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(B) mRNA levels of PKBα and (C) PKBβ, respectively, were determined using total RNA 
from 6 different organs of adult PKBγ wild type (n=3; black bars) and mutant mice 
To investigate whether the ablation of PKBγ leads to compensatory increase of PKBα 
and/or PKBβ, total RNA was isolated from brain, testis, lung mammary gland, fat and 
spleen of 3 PKBγ wild type and 3 mutant mice and a quantitative RT-PCR was 
performed as described (Yang et al., 2003). The levels of PKBα and β were 
normalized to the level of PKBα in the wild type brain and set as 100%. Overall, no 
marked up-regulation of PKBα and/or PKBβ was observed, including the brain 
(Fig.2.2 B and C). These results are consistent with the findings of the Western blot 
analysis with protein extracts of brains from PKBγ wild type and mutant mice (Fig.2.1 
D). 
Dispensable role of PKBγ for postnatal survival, fertility and body weight  
Recently, it has been shown by independent groups that mice with targeted disruption 
of the PKBα gene display an increased neonatal mortality (Chen et al., 2001; Cho et 
al., 2001b; Yang et al., 2003). Therefore, we investigated whether Pkbγ -/- mice were 
born at/in the expected Mendelian ratio. Analysis of more than 400 pups (age: 3-4 
weeks) from PKBγ heterozygous matings revealed no evidence for an increased 
mortality of PKBγ -/- mice after birth (Pkbγ +/+: Pkbγ +/-: Pkbγ -/- = 104 (25.6%): 206 
(50.7%): 96 (23.6%)). Since PKBγ is highly expressed in the testis, fertility of mutant 
mice was tested using male Pkbγ  -/- x female Pkbγ +/+ and female Pkbγ  -/- x male Pkbγ 
+/+ matings, respectively. Both male and female knock out mice matings gave normal 
pregnancies and births, indicating that fertility is not impaired in either male or female 
PKBγ mutant mice. PKB has been implicated in cell and organ growth (Yang et al., 
2004). Previously it has been reported that, besides the increased mortality, mice with 
Pkbα, Pkbβ and Pkbαβ null mutations also present a mild to severe growth retardation 
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syndrome (Chen et al., 2001; Cho et al., 2001b; Garofalo et al., 2003; Peng et al., 
2003; Yang et al., 2003). Therefore, body weight was measured in male Pkbγ knock 
out mice and wild type littermate controls (n=5-8 per group) at different time points 
and the obtained results are shown in Fig.2.3 A. The body weight did not differ 
significantly between Pkbγ mutant mice and wild type controls at any time point. A 
similar result was observed using female Pkbγ -/- mice and Pkbγ +/+ controls (n=5-8, 
data not shown), indicating a dispensable role of PKBγ for body weight control.  
Essential role of PKBγ for postnatal brain development 
For further analysis, Pkbγ +/+ and Pkbγ -/- mice were dissected and all major organs 
were investigated macroscopically. Compared to Pkbγ +/+ controls, the overall size of 
the brain from adult Pkbγ -/- mice was strikingly reduced. A representative example is 
shown in Fig.2.3 C-E. Subsequently, the weights of freshly dissected brains of Pkbγ 
wild type and Pkbγ mutant mice were measured at different ages and the results are 
shown in Fig.2.3 B. Compared to age and gender matched wild type littermate 
controls, brains from adult Pkbγ -/- mice exhibit a highly significant reduction (p<0,01) 
of brain weight. In adult Pkbγ -/- mice the brain weight was reduced about 25% (range: 
22%-29%) affecting both male and female mice. But in contrast to Pkbα, Pkbβ or 
IGF-I null mutant mice, the brain/body weight ratio of Pkbγ mutant mice was also 
significantly reduced to a similar extent (Beck et al., 1995; Cheng et al., 1998; Powell-
Braxton et al., 1993).The reduction of brain size and weight was first observed at the 
age of 1 month, but less pronounced (18%). Interestingly, at birth the brain weight did 
not differ significantly between Pkbγ +/+ and Pkbγ -/- (Fig.2.3B). 
In vivo Magnetic resonance Imaging (MRI) of Pkbγ mutant mice 
MRI has been shown to be an excellent tool to study brain anatomy in transgenic and 
mutant mice (Kooy et al., 1999; Lin et al., 2003; Natt et al., 2002). For further 
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characterization of the Pkbγ mutant brain anatomy, 5 adult female knock out and 5 
adult female wild type littermate controls were examined using conventional MRI.  
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Figure 2.3 Reduced brain size in adult PKBγ mutant mice 
(A) Body weight of male Pkbγ +/+ and Pkbγ-/- mice was measured at different time points (n=5-8 
per genotype).  
(B) Weight of freshly dissected brains of male Pkbγ +/+ and Pkbγ -/- mice were measured at 
different time points (n=5-8 per genotype). P-values below 0.05 were indicated with an 
asterisk.  
(C) Cranial, (D) caudal and (E) lateral view of brains from adult PKBγ wild type (left side) 
and knock out (right side) mice. Various brain structures are labeled as followed: CO= cortex, 
CE= cerebellum, OB= olfactory bulb, BS= brainstem, HY= Hypothalamus 
 
Mice were anesthetized and intubated, and T2-weighted MRI were obtained as 
previously described (Natt et al., 2002). Representative images of sagital, horizontal 
and coronal section from Pkbγ +/+ and Pkbγ -/-, respectively, are shown in Fig.2.4 A-F. 
The in vivo MRI confirmed the dramatic reduction of brain size in all 5 PKBγ -/- mice. 
Compared to wild type littermates, the volume of the whole brain from PKBγ -/- mice 
was significantly reduced about 25% (513±14 vs. 391±16 mm3, p<0.01). MRI 
 88
confirmed that various brain regions were affected, including cortex, cerebellum, 
hippocampus, olfactory bulb and ventricular spaces. But no alteration in the structural 
organization of the brain was observed, confirming the macro-pathological findings. 
Furthermore, an external hydrocephalus was excluded as a cause of the reduced brain 
size. Interestingly, in all 5 PKBγ -/- mice, but in none of the 5 wild type controls, an 
impressive reduction of the anterior part of the corpus callosum was observed (Fig. 2.4 
C-F). Other   commissures such as anterior, posterior or hippocampal commissure 
were not or less severely affected.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 89
Figure 2.4 Magnetic resonance images of brains from adult PKBγ mutant mice 
PKBγ wild type and mutant littermate controls (n=5 per group, all female, 4 months old) 
underwent MRI and T2-weighted data were obtained. Representative pictures from Pkbγ +/+ (A, 
C and E) and PKBγ-/- mice (B, D and F) are shown in a sagital (A and B), horizontal (C and D) 
and coronal (E and F) plane. Various parts of the brain were labeled as followed: CO= cortex, 
CE= cerebellum and OB= olfactory. The corpus callosum is marked with arrowheads and the 
anterior commissure with an arrow.  
 
Histology of PKBγ wild type and mutant mice 
To investigate changes on the microscopical level, a histological examination of Pkbγ -
/- brain was performed. Various brain regions, including cerebellum, hippocampus, 
cortex and corpus callosum, were examined on Hematoxilin-Eosin stained sections and 
representative pictures are shown in Fig.2.5 A-H. Histological examinations did not 
reveal any abnormalities in the overall structure of the different brain regions, but with 
the exception of the reduced size of all regions. As seen in the MRI, the thickness of 
the corpus callosum in PKBγ mutant mice was impressively reduced (data not shown). 
Additionally, a myelin staining with Luxol fast blue performed (Fig.2.5 G-L). Myelin 
staining revealed not only a reduced thickness of the corpus callosum but also a less 
intensively stained structure. 
Cell number determination in the brain of in PKBγ mutant mice 
Since PKB is a key player involved in cell growth, proliferation and apoptosis, we 
assessed the cell number in the central nervous system by measuring the DNA content 
of whole brains from Pkbγ +/+ and Pkbγ -/- mice. The DNA content is considered a 
parameter for cell number and the DNA content per gram of tissue is considered a 
parameter of cell density (and inverse correlated to cell size) (Labarca and Paigen, 
1980; Zamenhof and van Marthens, 1976). The DNA content was determined in brains  
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Figure 2.5 Histology of brains from PKBγ mutant mice 
Hematoxylin/Eosyin (HE) stained parasagital sections of the cortex (A and B), hippocampus 
(C and D) and cerebellum (E and F) from Pkbγ +/+ (A, C and E) and Pkbγ -/- mice (B, D and 
F) are shown.  Brains of adult mice were dissected and stained for myelin (blue) with Luxol-
Fast blue and Eosin Y. Coronal section of whole brain (G and H), corpus callosum (I and J) 
and anterior commissure (K and L) from Pkbγ +/+ (G, I and K) and Pkbγ -/- mice (H, J and L) 
are shown. 
derived from newborn and 1-month-old mice. At 1 month the cell number in the brains 
from PKBγ mutant mice was slightly, but significantly, reduced when compared to 
PKBγ +/+ controls. In contrast, the DNA content in the brains of newborns did not 
differ significantly between PKBγ wild type and mutant mice. Additionally, at the 
stage of 1 month, the DNA content per gram of tissue was significantly increased in 
samples derived from Pkbγ -/- when compared to wild type littermate controls. Taken 
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together, the results suggest that both cell size and cell number contribute to the 
reduction of brain size observed in 1-month old mutant mice (table 2.1). 
Table 2.1 Cell number in the brain of Pkbγ  wild-type and mutant mice 
 Newborns 1 month old 
 Pkbγ +/+ Pkbγ -/- Pkbγ +/+ Pkbγ -/- 
Body weight (g) 1.21±0.23 1.31±0.14 (107%) 14.1±2.5 13.0±2.3 (92%) 
Brain weight (g) 0.071±0.001 0.069±0.006 (98%) 0.41±0.03 0.32±0.03 (78%) 
Brain/body weight 
ratio 
0.059±0.011 0.054±0.008 (90%) 0.030±0.004 0.025±0.003 (85%) 
DNA/brain (mg) 0.59±0.04 0.56±0.12 (96%) 1.38±0.03 1.29±0.07 (93%)* 
DNA/g of tissue (mg) 8.53±1.64 8.11±1.29 (95%) 3.38±0.20 4.04±0.47 (119%)* 
P-values below 0.05 were indicated with an asterisk.  
 
Myelination in PKBγ mutant mice  
Several recent studies emphasize the importance of insulin-like growth factor I (IGF-I) 
signaling in the survival and proliferation of oligodendrocytes and myelination in the 
central nervous system (D´Ercole et al., 2002). It has been reported that mice lacking 
IGF-1 have also a reduced brain weight with notable hypomyelination in the cortex, 
corpus callosum and anterior commissure (Beck et al., 1995; Ye et al., 2002). 
Therefore, a Western blot analysis with cell lineage specific markers was performed 
using antibodies against myelin basic protein, glial fibrillary acidic protein and M-
Neurofilament. Interestingly, no obvious difference was observed (n=6 per genotype, 
data not shown) 
Signaling in PKBγ mutant mice 
To further elucidate the mechanisms which could lead to a decreased brain size in 
PKBγ mice, the phosphorylation state of PKB itself and its substrates was determined 
in brains from Pkbγ +/+ and Pkbγ -/- mice using phospho-specific antibodies. First, we 
analyzed the phosphorylation/activation state of PKB in protein extracts from brain of 
Pkbγ +/+ and Pkbγ -/- using an antibody specific for the phosphorylation site (anti 
phospho-Ser 473) in the hydrophobic motif of the regulatory domain of all 3 isoforms 
(Fig.2.6). As expected, the total level of activated PKB in the Pkbγ -/- sample was 
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markedly reduced, but not completely abolished, when compared to the samples of 
Pkbγ +/+ littermate controls. The phosphorylation levels of glycogen synthase kinase 
(GSK), tuberous sclerosis complex 2 (TSC2), ERK, p27 and p70S6K were only 
slightly, if at all, changed in the Pkbγ -/- samples.  
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Figure 2.6 Phospho-Western blot analysis of brains from PKBγ mutant mice 
 
To check the phosphorylation status of proteins involved in PKB signaling, lysates from 3 wild 
type and 3 mutant brains were analyzed using various antibodies as indicated. Actin served as 
loading control (50 µg protein/lane). 
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Discussion 
In this article we report the phenotypic consequences of the ablation of the PKBγ gene. 
We demonstrated that the targeted disruption of the PKBγ gene by homologous 
recombination results in a complete ablation of the gene product. Furthermore, the 
inactivation of the PKBγ gene leads to a considerable reduction of the total 
phosphorylated/activated PKB in the mutant brain. Interestingly, the levels of the 
α and β isoform of PKB assessed on the mRNA and protein level in PKBγ mutant 
brains are not elevated and they fail to fully compensate for the loss of PKBγ. This 
result is consistent with the findings in PKBα and PKBβ mutant mice, where no 
compensatory up regulation of the other isoforms was found (Yang et al., unpublished 
observation, Cho et al., 2001, Garofalo et al., 2003). Our results show that, in contrast 
to PKBα and PKBβ mutant mice, PKBγ mice are viable and do not suffer from a 
growth retardation syndrome, suggesting a dispensable role in embryonic and postnatal 
body growth (at least not this particular genetic background).  
It has been recognized that the IGF-I/PI3-K/PKB pathway plays a crucial role in the 
mammalian brain development. Mice with targeted disruption of the IGF-I and insulin-
receptor substrate gene display a brain phenotype with a marked reduction of the brain 
mass (Beck et al., 1995; Schubert et al., 2003; Ye et al., 2002).  In contrast, an 
increased brain mass was observed in mice overexpressing IGF-1 (Mathews et al., 
1988; Ye et al., 1995). Moreover, mice with brain specific deletion of PTEN, a 
negative regulator of the PI3-K/PKB pathway, exhibit an enlarged brain with seizures 
and ataxia resembling Lhermitte-Duclos disease (Backman et al., 2001; Kwon et al., 
2001). Unfortunately, less is known about the consequences of the inactivation of 
PKBα and PKBβ for the mouse brain development. PKBα −/− and PKBβ  mice show 
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only a slight diminution of brain weight, but both present an increased brain/body 
weight ratio (Yang et al.,, unpublished observation, Garofalo et al., 2003).  
However, inactivation of the PKBγ gene results in impressive weight and size 
reduction of the brain in adult mice. In contrast to the PKBα PKBβ and IGF-I mutant 
mice, the brain/body weight ratio was also significantly reduced. Interestingly, PKBγ 
deficiency did not affect the general anatomical organization of the brain and a missing 
brain region could be excluded by MRI analysis as the main cause of the weight 
reduction. MRI revealed various affected brain regions, including cerebellum, cortex, 
hippocampus or ventricular spaces.  
PKBαγ double mutant mice provide supplementary information of the crucial role of 
PKB in brain development. Besides the complete embryonic mortality and the severe 
growth retardation, they exhibit a defective development of brian (Yang et al., 
unpublished observation). 
To determine the specific role of the different PKB isoforms in brain development, 
mice with a brain specific deletions (Cre/Lox system) of a single isoform will be 
generated and help to answer these questions. Although we have not observed obvious 
differences in the behavior between PKBγ wild type and mutant mice, sophisticated 
behavioral studies are needed to test behavior under more challenging conditions (e.g. 
rotarod for motor function) and for less obvious brain functions (e.g. memory). 
As mentioned above, mice with targeted disruption of a single PKB isoform were 
generated and all demonstrate a distinct phenotype. Interestingly, the PKBβ knock out 
mice exhibit a diabetes-like syndrome with hyperglycemia and impaired insulin action 
in fat, liver and skeletal muscle and, depending of the genetic background, mild growth 
retardation (Cho et al., 2001, Garofalo et al., 2003). However, mice deficient in PKBα 
revealed a normal glucose metabolism, but display an approximately 30% reduction in 
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body size and partial neonatal lethality, which might be caused by placental 
insufficiency (Cheng et al., 2001, Cho et al., 2001, Yang et al., 2003). Recently, Peng 
and colleagues reported the successful generation of PKBαβ double mutant mice. 
They exhibit a severe intrauterine growth retardation syndrome and they die briefly 
after birth. Moreover, they present multiple defects in the skin, bone and fat (Peng et 
al., 2003). It has been speculated that the distinct phenotypes of PKBα and PKBβ 
mutant mice are due to specific and separate functions of the disrupted PKB isoform. 
Previously, Peng and colleagues proposed an alternative explanation for the individual 
phenotypes (Peng et al., 2003). They hypothesized that the individual phenotype could 
be due to the loss of the dominant isoform in a special tissue, which leads to a 
significant reduction of the total activated PKB below a critical level. For example, the 
observed diabetes mellitus-like syndrome of PKBβ -/- mice could be due the ablation of 
the dominant isoform  (PKBβ) in the classic insulin responsive tissue like fat, liver and 
muscle. Additionally, the loss of a second isoform would have an additive effect in 
reducing the total PKB and therefore would intensify the phenotype. This proposition 
is further supported by our initial observation from the PKBαγ double knock out mice. 
The additional ablation of a single copy of PKBγ in PKBα deficient mice leads to an 
even more increased perinatal mortality, and the ablation of both PKBγ alleles leads to 
intrauterine death of PKBαγ double knock out (Yang et al., unpublished data). 
However, it cannot be ruled out yet that the observed phenotypes are due to a 
combination of both the reduced total PKB level and the loss of an isoform-specific 
function. 
It has been shown that the PI3-K/PKB signaling pathway plays a crucial role in the 
determination of cell size (Scanga et al., 2000; Shioi et al., 2002; Tuttle et al., 2001a; 
Verdu et al., 1999b). Results from Transgenic mice over-expressing PKB showed an 
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increased size of cardiac myocytes, larger thymocytes or hypertrophy and hyperplasia 
in the pancreas (Kovacic et al., 2003; Mangi et al., 2003). In mice with brain specific 
deletion of PTEN an increased neuronal soma size was observed (Backman et al., 
2001; Kwon et al., 2001). In contrast, in PKBαβ double mutant mice the size of 
skeletal muscle cells was dramatically reduced (Peng et al., 2003). Our results show 
that both cell number and cell size are affected, but the relative contributions of the cell 
size reduction seems to be more prominent than the reduction of cell number. 
Additionally, it has been shown that the mTor signaling pathway is also involved in 
the determination of cell size (Montagne et al., 1999; Oldham et al., 2000; Zhang et al., 
2000). PKB modulates mTor activity by phosphorylating TSC2 with a subsequent 
disassembling of the TSC1-TSC2 complex (Inoki et al., 2002, Manning et al., 2002, 
Potter et al., 2002). However, we observed only a slight reduction of the 
phosphorylation level of TSC2 and p70S6Kinase in the brains of PKBγ mutant mice. 
Taken together, we demonstrated that PKBγ deficient mice display a distinct 
phenotype when compared to PKBα and PKBβ mutant mice. We emphasized the 
importance of PKB in determination of cell size and number. Our study provides novel 
insights into the function of PKBγ and suggests a critical role in the postnatal brain 
development in mammals. 
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SUMMARY 
The three protein kinase B (PKB/Akt) isoforms ⎯PKBα/Akt1, PKBβ/Akt2 and 
PKBγ/Akt3 display multiple similarities in domain structure and cellular 
function. Given that PKB is essential for cell survival, the existence of viable 
knockout mice for each gene suggests redundancy of the three proteins. 
Nevertheless, each deletion causes distinct phenotypes, indicating different 
physiological roles. Here we show that Pkbα -/-Pkbγ +/- compound mutant mice 
display multiple organ/tissue pathology and the majority die early, whilst Pkbα +/-
Pkbγ -/- mice survive normally.  Double knockout (Pkbα -/-Pkbγ -/-) causes embryo 
lethality at around E12, with developmental defects in the placenta, brain and 
branchial arch arteries. These data indicate that PKBα is more essential than 
PKBγ for animal survival, but that both are required for placenta and embryo 
development. There are also suggestions of isoform-specific and dosage-
dependent effects of PKB on animal survival and development. 
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INTRODUCTION 
Protein kinase B (PKB, also known as Akt) belongs to a subfamily of serine/threonine 
protein kinases called AGC protein kinases that includes protein kinase C (PKC), 
ribosomal S6 kinase (S6K), the cyclic-AMP-dependent protein kinase (PKA), the 
serum and glucocorticoid-induced protein kinase (SGK) and others (Brazil and 
Hemmings, 2001; Lawlor and Alessi, 2001). In mammals such as mouse, rat and 
human, the PKB family consists of three isoforms, PKBα/Akt1, PKBβ/Akt2 and 
PKBγ/Akt3, encoded by three independent genes on distinct chromosomes (Brazil and 
Hemmings, 2001; Datta et al., 1999; Lawlor and Alessi, 2001; Scheid and Woodgett, 
2001). In mouse and humans, PKBα, β and γ proteins are made up of 480, 479 and 481 
amino acids respectively, and have similar domain structures: N-terminal pleckstrin 
homology (PH) domain, intermediate catalytic domain and C-terminal regulatory 
domain. The amino acid constitution of the catalytic domain in these proteins is almost 
identical. All three proteins can be activated by numerous growth factors in a 
phosphatidylinositol 3-kinase (PI 3K)-dependent manner at the cell membrane (Brazil 
and Hemmings, 2001; Datta et al., 1999; Lawlor and Alessi, 2001; Scheid and 
Woodgett, 2001).  
Approximately30-40 proteins have been reported to be substrates of PKB. The 
majority of these substrates have a consensus motif of RXXRXS/T, where X can be 
any amino acid and S/T is the serine/threonine phosphorylation site of PKB (Brazil 
and Hemmings, 2001; Lawlor and Alessi, 2001). Determination of this motif in a 
protein and its conservation in several vertebrate homologue can be used to predict 
PKB substrates. Based on this, Yaffe and Cantley developed a computer programme to 
score all known proteins in a database search for PKB targets, which can facilitate the 
discovery of novel proteins in the PKB signalling pathway and help to understand 
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PKB functions (Yaffe et al., 2001). The functions of numerous identified or predicted 
substrates indicated that PKB is involved in many cellular and physiological processes 
such as cell survival, cell cycle progression, cell growth, metabolism and angiogenesis.  
Although many proteins have been identified as PKB substrates through in vitro 
biochemical studies and in vivo cell transfection assays, the challenge that remains is to 
show that they actually have an important impact on physiological processes in 
organisms. Studies in Drosophila of PKB (dAkt) overexpression and mutation have 
recognized its importance in organimal growth regulation and have confirmed the 
predicted functions of PKB (Leevers et al., 1996b; Stocker et al., 2002; Verdu et al., 
1999a). Recently, targeted deletion of specific isoform of PKB in mouse has proved to 
be a powerful tool for elucidating the physiological roles of PKB proteins (Chen et al., 
2001; Cho et al., 2001a; Cho et al., 2001b; Garofalo et al., 2003; Yang et al., 2003). 
Characterization of such knockout mice has yieled intriguing and surprising results. 
First, we and others have found that inactivation of a single PKB isoform does not 
affect embryo development of animal, despite the fact that ~ 40% of Pkbα knockout 
mice die at a neonatal stage. This suggests that the other two PKB isoforms can 
compensate for the absence of PKBα (Chen et al., 2001; Cho et al., 2001b; Yang et al., 
2003). However, no upregulation of the other two isoforms was observed at the protein 
level. Second, knockout of each single isoform gives rise to a distinct phenotype. In 
general, PKBα null mice are small in size, which may result from placental 
insufficiency, while PKBβ-deficient mice develop a type 2 diabetes-like syndrome 
(Chen et al., 2001; Cho et al., 2001a; Cho et al., 2001b; Garofalo et al., 2003; Yang et 
al., 2003). These observations, on the other hand, indicate that the three PKB isoforms 
have different non-redundant physiological functions. As mentioned above, PKB 
proteins have a very high homology with similar domain structures, and show identical 
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functions in cell transfection assays. The relatively normal development and distinct 
physiological functions demonstrated by single knockouts may be explained by 
differences at the tissue distribution and expression levels of these isoforms. For 
example, in the major insulin responsive tissues of fat, skeletal muscle and liver, PKBβ 
is the predominant isoform (Altomare et al., 1998a; Cho et al., 2001a; Yang et al., 
2003). Inactivation of this isoform in mouse may greatly affect glucose metabolism 
and causes diabetes. Similarly, we found that PKBα is the major isoform in placenta 
and that placenta lacking this protein can not form a proper vascular structure; this may 
restrict nutrient supply to the foetus and impair growth (Yang et al., 2003).  
Thus, one could expect that simultaneous inactivation of two PKB isoforms in mice 
would severely affect development and survival. Recently, it was shown that double 
knockout mice of PKBα/β die shortly after birth (Peng et al., 2003). These mice 
displayed a more obvious phenotype than single knockout mice, including dwarfism, 
impaired skin development, skeletal muscle atrophy and abnormal bone development. 
However, the results are surprising in that one isoform (PKBγ) is still sufficient for 
animals to develop to term. 
We crossed Pkbα/Pkbγ knockout mice to generate compound and double knockout 
mice. Our observation shows that PKBα is more important than PKBγ for survival and 
that both proteins are required for normal embryo development. Our studies 
demonstrate isoform-specific and dosage-dependent effects of PKB proteins in 
physiology, animal survival and development. 
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METHODS 
Mice 
The animal work was performed in accordance with the Swiss law on animal welfare 
and protection. Pkbα -/- mice have been described previously (Yang et al. 2003). The 
generation of Pkbγ null mice was described elsewhere (Tschopp et al. submitted). 
Pkbα -/- males were mated with Pkbγ -/- females to produce double heterozygous mice 
(Pkbα+/-Pkbγ +/-). Intercross of double heterozygous mice gave rise to compound mice 
with 9 genotypes that were analysed by PCR. Primers used for genotyping were as 
described previously (Yang et al., 2003; Tschopp et al., submitted). Matings between 
Pkbα+/-Pkbγ -/- males and Pkbα -/- females were set up in order to examine the postnatal 
survival of Pkbα -/- Pkbγ +/- mice. The progeny were all Pkbγ +/- and half of them were 
Pkbα -/- ( half Pkbα -/- Pkbγ +/- ). To increase the number of double knockout mice, we 
set up matings between Pkbα+/-Pkbγ -/- males and females. The percentage of double 
knockout mice was 25%. All these mice had 129 Ola and C57BL/6 mixed background. 
BrdU incorporation 
E10.5 to E11.5 pregnant mice were injected intraperitoneally (IP) with BrdU (1mg/20g 
body weight). The mice were sacrificed 2 h later and embryos together with placentas 
were dissected. After washing with PBS, the samples were fixed in formalin at 4oC 
overnight. Cryosections were prepared for staining. 
Histology 
After dissection, embryos and tissues were treated by, fixation in 10% formalin at 4°C  
overnight; washing in PBS at 4°C for 30 min, washing in 0.85% NaCl (in H2O) at 
room temperature for 30 min, washing twice in 50% EtOH (in 0.85% NaCl) at room 
temperature for 20 min, washing twice in 70% EtOH (in PBS) at room temperature for 
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20 min. Treated samples were processed for paraffin embedding and 10 µm sections 
cut for haematoxylin and eosin staining. 
The immunohistochemistry protocol was as described previously (Yang et al., 2003). 
Briefly, tissues or embryos were fixed in formalin at 4oC overnight, transferred to 0.5 
M sucrose/PBS solution at 4oC overnight,  and washed in PBS. Then the samples were 
embedded in OCT compound (Tissue Tek) and 20 µm sections cut. The sections were 
treated with 0.3% H2O2 in methanol for 30 min to inactivate endogenous peroxidase, 
blocked in 5% normal goat serum in PBS for 30 min, and then incubated at 4oC 
overnight with antibody for PKBα and γ (Yang et al., 2003) as well as BrdU, and 
PECAM (Pharmingen). The sections were then processed as described in the protocol 
of the Vectastain ABC kit (Vector Laboratories).  
 
RESULTS 
Dominant role of PKBα over PKBγ in postnatal mouse survival  
Pkbα and Pkbγ genes have been successfully targeted by homologous recombination 
in our lab (Yang et al., 2003;Tschopp, submitted). Previously, we observed that the 
Pkbα -/- mice develop to term and that around 60% of these mice survive normally 
(Yang et al., 2003). Similarly, Pkbβ -/- and Pkbγ -/- mice also develop normally during 
gestation. Nevertheless, Pkbβ -/- and Pkbγ -/- mice did not show increased postnatal 
mortality (Cho et al., 2001a; Garofalo et al., 2003). It is well known that PKB proteins 
play pivotal roles in multiple cellular and physiological processes, such as cell survival 
and angiogenesis, that are essential for normal embryo development. However, the 
existence of viable single knockout mice for each isoform suggestss functional 
redundancy of the three proteins. The presence of any two PKB proteins can meet the 
developmental requirements of mice. Given that around 40% of Pkbα -/- mice die 
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neonatally, it is highly possible that inactivation of PKBβ or PKBγ together with 
PKBα has a severe impact on animal development, and intensifies morbidity and 
increases mortality of the mice. To test this, we crossed Pkbα and Pkbγ mutant mice to 
produce various compound mice. We first mated Pkbα -/- males with Pkbγ -/- females to 
generate Pkbα+/-Pkbγ +/- (double heterozygous) mice. Except for mild growth 
retardation (~10% smaller than wild-type at birth), these mice had no apparent defects 
and grew normally. Intercross of these double heterozygous mice gave rise to offspring 
with 9 genotypes (Table 3.1) genotyped at around 1 month old. The number of Pkbα+/-
Pkbγ -/- mice was in accordance with the expected Mendelian ratio and these mice 
appeared normal (Table 3.1).   
 
 
 
 
 
 
 
However, very few Pkbα -/-Pkbγ +/- mice (3 vs 37 of Pkbα+/-Pkbγ -/-) survived at the 
time of genotyping. These results supported our hypothesis that haplo-insufficiency of 
PKBγ in Pkbα -/- mice intensifies the phenotype and reduces the survival of the mice. 
Actually, the mortality increased from ~ 40% in single Pkbα -/- mice to ~90% in Pkbα -
/-Pkbγ +/- mice, while Pkbγ -/- and Pkbα+/-Pkbγ -/- mice did showed no increase in 
mortality. These results suggested that PKBα is more important that PKBγ for animal 
survival. 
Table 3.1. Progeny of Pkbα+/-Pkbγ +/- Matings 
Genotype α+/+γ +/+ α+/+γ +/- α+/+γ -/- α+/-γ +/+ α+/-γ +/- α+/-γ -/- α-/-γ +/+ α-/-γ +/- α-/-γ -/- 
Number of 
animals 27 34 20 31 74 37 11 3      0 
Percentage 11.3 14.3 8.4 13 31 15.5 4.6 1.3      0 
Theoretical  
percentage 6.3 12.5 6.3 12.5 25 12.5 6.3 12.5    6.3 
Total number:237 
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Pkbα -/-Pkbγ +/- mice display severe growth retardation and multiple organ/tissue 
pathology  
As approximately 90% of the Pkbα -/-Pkbγ +/- mice were lost before genotyping at 
about 1 month old, we determined at what stage these mice die. Matings were set up 
between Pkbα+/-Pkbγ -/- males and Pkbα -/- females. Theoretically, offspring of this 
mating are half Pkbα -/-Pkbγ +/- and half Pkbα+/-Pkbγ +/- (1:1). Of the 20 newborns 
collected from 4 litters, 8 were Pkbα+/-Pkbγ +/- and 12 Pkbα -/-Pkbγ +/-, which is 
consistent with the Mendelian ratio. Therefore, Pkbα -/-Pkbγ +/- can develop to term. 
Bodyweight of Pkbα -/-Pkbγ +/- newborns was comparable to that of Pkbα -/- (Pkbα -/-
Pkbγ +/- 1.064 ± 0.11g; Pkbα -/- 1.099 ± 0.11g, P=0.46; Table 3.2). This indicates that 
haplo-insufficiency of PKBγ in a PKBα-null background has little effect on the growth 
of embryos. Follow-up observations of the Pkbα -/-Pkbγ +/- mice revealed severe 
growth deficiency and these mice died within 10 days (Fig 3.1A, Table 3.2). Newborns 
and 3-day-old Pkbα+/-Pkbγ +/- and Pkbα -/-Pkbγ +/- littermates were sacrificed and major 
organs/tissues were dissected for macroscopic and histological studies. The stomachs 
of Pkbα -/-Pkbγ +/- mice contained milk, indicating ability to suck (Fig 3.1E). The 
thymuses of   
 
 
 
 
 
 
 
 
 
 
Table 3.2 Body Weight of WT, Pkbα -/-,  Pkbα +/-γ +/- and Pkbα -/-γ +/- Mice 
Body weight: g WT Pkbα -/- Pkbα +/- γ +/- Pkbα -/-γ +/- 
Newborn (P1) 
(mean ± SD) 
1.49 ± 0.16 
(n=15) 
1.099 ± 0.11 
(n=11) 
1.33 ± 0.1 
(n=8) 
1.064 ± 0.11 
(n=11) a 
P3 
 
N/A 
 
N/A 
 
2.29 ± 0.31 
(n=4) 
1.465 ± 0.33 
(n=6) b 
a) The difference in body weight of Pkbα -/- and Pkbα -/-γ +/-newborns was not 
significant (P=0.46). 
b) Pkbα -/-γ +/- mice grew slower than Pkbα +/-γ +/- littermates. 
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Figure 3.1. Severe Growth Deficiency and Multiple Pathology of Pkbα -/-γ +/- Mice. 
(A-F) Three-day-old Pkbα +/-γ +/- and Pkbα  -/- γ +/- littermates together with their organs. In each 
panel, left is Pkbα +/-γ +/- and right Pkbα  -/-γ +/-. 
(A) Mice. (B) Thymus. (C) Heart, anterior side. (D) Heart, posterior side. (E) Stomach. Both 
are full of milk. (F) Skin, interior side (from the back, the heart level). 
(G-L) Histological studies of the skin, thymus and heart from Pkbα +/-γ +/- and Pkbα  -/-γ +/- mice. 
(G) (I) (K) Pkbα+/-γ +/- and (H) (J) (L) Pkb α -/-γ +/-. (G,H) Skin. x100. (IJ) Thymus. x40. (KL) 
Heart, transverse sections. x40. 
 
Pkbα -/-Pkbγ +/- mice were atrophied (Fig. 3.1B). Haplo-insufficiency of PKBγ together 
with PKBα loss mainly affected the size of heart ventricles; atria size was similar to 
that of Pkbα+/-Pkbγ +/- littermates (Fig 3.1C, D). The skin of Pkbα -/-Pkbγ +/- mice was 
loose and thin with scarcely visible subcutaneous vasculature (Fig. 3.1D). The density 
of adnexal structure was similar in Pkbα -/-Pkbγ +/- mice and wild-type, but dermal and 
subcutaneous mesenchymal tissue was diminished in the mutant, particularly 
subcutaneous fat and adnexal structures positioned close to each other (Fig. 3.1G and 
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1H). Hassal’s corpuscles formed in the thymus of Pkbα -/-Pkbγ +/- mice and starry sky 
cortical apoptosis was apparent; this is attributable to increased stress of asphyxia (Fig. 
3.1I,J). Intramyocardial vessel density was reduced in the hearts of Pkbα -/-Pkbγ +/- 
mice. Myocardial muscle fibres were shorter and not as well aligned as in Pkbα+/-
Pkbγ +/- mice. In addition, trabecular muscle was less compact in Pkbα -/-Pkbγ +/- hearts 
(a minor degree of ‘non-compaction’). 
 PKBα and PKBγ are required for mouse development 
Genotyping of progeny from Pkbα+/-Pkbγ +/- double heterozygous intercrosses at the 
time of weaning showed that no double knockout mice survived (Table 3.1). Because 
the majority of the Pkbα -/-Pkbγ +/- mice die young, it is highly possible that double 
knockout mice were lost during gestation. To test this, we set up matings between 
Pkbα+/-Pkbγ -/- males and females to increase the number of double knockout 
progenies (1 in 4 is a double knockout). Dissection at E14 detected no double 
knockout embryos. E11 embryos were dissected and genotyped and double knockout 
embryos were found with morphology comparable to Pkbα +/+Pkbγ -/- littermates. The 
isolation of embryos one day later at E12 showed that some double knockout embryos 
had either already disappeared, leaving only the placenta, or they had abnormal 
morphology (Table 3.2, and Fig. 3.2A-C). These data indicate that double knockout 
mutants die between E11 and E12.  
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Figure 3.2. E10.5 and E11.5 Embryos. 
(A) Immunohistochemistry with PKBα/γ antibody showing the absence of the two proteins in 
E10.5 double knockout embryos. 
(B) E10.5 littermates. Note the abnormal development and morphology of one double 
knockout embryo. 
 (C) E11.5 littermates. Only some remnants of the double knockout embryos are left. 
WT, wild-type; DKO, double knockout; Dhe, double heterozygous. 
Tissue distribution of PKBα/γ in E11.5 and 12.5 embryos 
Because Pkbα -/-Pkbγ -/- mice die between E 11 and 12, we studied the localization of 
the two isoforms in wild-type embryos at these stages to determine where they 
function. Immunohistochemical staining was performed on cryosections with an 
antibody recognizing both mouse PKBα and γ but not β. At E11.5, these two proteins 
were mainly in the central nervous system and heart (Fig. 3.3A-F). At E12.5, they 
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were expressed at high levels in the central and peripheral nervous system, including 
the brain and various ganglia (Fig. 3.3G-J). These tissue distribution patterns may 
indicate that the two proteins are important for brain and cardiovascular development 
at E11.5 to 12.5. 
 
 
 
 
 
 
 
 
 
 Figure 3.3. PKBα/γ Distribution in E11.5 and E12.5 Mice. 
(A-F) E11.5. (A) (C) (E) H&E staining and (B) (D) (F) immunohistochemical staining with 
PKBα/γ antibody. (E) (F) showing the heart. 
(G-J) E12.5. (G) (H) H&E staining and (I) (J) Immunohistochemical staining with PKBα/γ  
antibody. The arrows indicate various ganglia. 
Abnormal development in double knockout embryos 
At E11, wild-type mice showed branchial arch development corresponding to 11 days, 
with prominent bulging of branchial arch contours (Fig. 3.4A). One or two larger and 
many smaller vascular channels were visible within the mesenchyme of each of the 
first two to three branchial arches, with delicate branching into multiple small vascular 
channels in the subcoelomic area. The delicate small vessels were not well defined in 
conventional histology but were highlighted by PECAM staining (Fig. 3.4A). The 
dorsal aorta ran along the mesenchyme, separating the dorsal aspect of the neural tube 
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towards the caudal somites from the coelomic cavity, and showed a medium lumen 
diameter (not shown). The forebrain, midbrain and hindbrain displayed a regular 
circular structure with multiple layers of cells (Fig. 3.4C). 
In contrast, the PKBα/γ double knockout mice demonstrated hypoplastic, hardly 
scalloped branchial arches with only little mesenchyme (Fig. 3.4A). Vessels within the 
branchial arches were fewer than in the wild-type mice but had diameters twice that of 
the wild-type vessels. Subcoelomic ramifications of these vessels in the branchial 
arches were scarce and only little mesenchyme was formed around the blood vessels. 
Similarly, the dorsal aorta was larger than in wild-type mice (not shown). The neural 
tube appeared multiloculated in the double knockout mice and the perineural 
mesenchyme was permeated by multiple irregular dilated and thin-walled vascular 
channels. Brain structure was disrupted in some embryos (Fig. 3.4B). This phenotype 
was more prominent in E12 embryos (Fig. 3.4C). The delicate edges of the brains were 
curled and folded, with extremely low cellularity (Fig. 3.4B, C). BrdU staining of E11 
embryos showed no large differences between wild-type and double knockout mice 
(Fig. 3.4B). However, the decreased and altered cell layers in the brain indicate 
abnormal differentiation of the neural cells in double knockouts. 
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Figure 3.4. Histological Analysis of E11 and E12 Embryos. 
(A) Branchial arch and its vasculature in E11 embryos. Note that the branchial arch of double 
knockout embryo is hypoplastic with a dilated artery, and that there are fewer micro-vessels. 
(B) BrdU staining of E11 embryos. In the DKO1 embryo, the brain structure is disrupted with 
fewer cell layers. In the DKO2 embryo, the cellularity in the brain is low. 
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(C) E12 embryos. The DKO embryo shows irregular and curled brain architecture, especially 
in the forebrain. 
Altered placental development in double knockout mutant mice 
Previously, we found defects in placental architecture in PKBα null mice, including 
hypotrophy, loss of glycogen-containing spongiotrophoblast cells and reduced 
vascularization (Yang et al., 2003). As placental growth and development proceed 
until E17.5, we performed BrdU staining with E11 placentas to study cell proliferation. 
In the wild-type placenta, the spongiotrophoblast cells showed prominent proliferation 
signals, while the signals were much weaker and the spongiotrophoblast layer could 
not be discerned in double knockout placenta (Fig. 3.5A-F). In E12 placentas, 
alteration of the labyrinth was apparent with double knockout placenta. The total area 
was reduced significantly (Fig. 3.5G-I) and both H&E and PECAM staining showed 
massive reduction in foetal vessels (Fig. 3.5J-O). In wild-type placenta, foetal vessels 
were broadly and evenly distributed within maternal blood spaces and filled with foetal 
immature nucleated erythroid cells. In the double knockout placenta, there were many 
endothelial cells but not in the form of vessel structures.  
DISCUSSION 
Here we report observations of PKBα/γ compound knockout mice. Loss of PKBα 
together with haplo-insufficiency of PKBγ caused severe post-natal survival 
consequences in these mice. The mice showed serious growth deficiency and nearly all 
died young with multiple organ/tissue pathology. Mice lacking both proteins were 
embryo lethal at around E12 and displayed fatal developmental defects. These results 
differ from those with PKBα/β compound knockout mice and have significant 
implications. 
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Isoform-specific and dosage-dependent effects of PKB on mouse survival  
In the single knockouts of PKB isoforms, PKBβ and PKBγ null mice had no neonatal 
survival disadvantages. Nevertheless, we and others observed that around 40%  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Histological Studies of E11 and E12 Placentas. 
(A-F) E11 placentas. (A) (B) (C) H&E staining and (D) (E) (F) BrdU staining. In wild-type 
placenta, the layer of spongiotrophoblasts shows strong proliferation signals, whilst the signals 
are dramatically reduced in the double knockout placentas. 
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(G-O) E12 placentas. (G)-(L) H&E staining and (M) (N) (O) PECAM staining. (G-I) In the 
double knockout placentas, the total area of labyrinth is significantly reduced compared with 
the wild-type. 
(J-L) Higher magnification of (G-I). 
(M-O) In the wild-type placenta, foetal vessels are distributed among the maternal blood 
spaces but in the double knockout placentas, very few foetal vessels were found. 
 
of PKBα null mice fail to survive the neonatal age (Cho et al., 2001b; Yang et al., 
2003). This raises the intriguing possibility that PKBα is the most critical isoform of 
the three for animal survival. 
No indications of post-natal survival difficulties was found with Pkbα -/-Pkbβ +/- mice 
(Peng et al., 2003). However, we found that Pkbα -/-Pkbγ +/- mice have increased post-
natal mortality from ~40% in single Pkbα -/- mice to ~90%. Therefore, PKBγ also 
contributes to animal survival. This hypothesis is supported by the developmental 
status of PKBα/β and PKBα/γ double knockout mice. PKBα/β double knockout mice 
with only PKBγ develop to term. But in the presence of only PKBβ in PKBα/γ double 
knockout mice, the mice do not develop beyond the mid-term. This indicates a more 
important role for PKBγ than PKBβ in animal development and survival. Based on 
this, given the presence of PKBα in PKBβ/γ double knockout mice, these animals 
should survive the whole gestation. 
Previously, we examined the expression levels of the three PKB mRNA in mouse 
tissues and organs by quantitative PCR. At least two isoforms were expressed in each 
tissue/organ (Yang et al., 2003). Earlier comprehensive and intensive studies using cell 
transfection assays showed that the three PKB proteins have similar properties in terms 
of their activation by growth factors such as insulin and insulin-like growth factors, 
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and subsequent phosphorylation of substrate proteins like GSK3 (Brazil and 
Hemmings, 2001). Therefore, the isoform-specific effects observed in single and 
double knockout mice may result from differences in tissue distribution and expression 
levels of the three isoforms, which are determined by the organisms according to 
physiological necessity. In another word, the non-isoform-specific effects of the three 
PKB proteins in cell transfection studies become isoform-specific in physiology. 
The essential role of PKBα/γ in mouse development  
In the past, extensive studies of PKB proteins produced the undisputed conclusion that 
PKB is a powerful opponent of apoptosis. This may oversimplify the roles of multi-
faceted PKB in physiology.  The phenotype manifested by PKBβ null mice has 
clarified this point. Nothing related to apoptosis was observed in these mice but, 
instead, the pivotal roles of PKB in regulating glucose metabolism and insulin action 
have been confirmed and are now well accepted.  
In this study, we have demonstrated that PKBα and PKBγ are essential for 
embryogenesis and development. In our previous study with PKBα null mice, we 
showed that this protein is an important regulator of placental development and foetal 
growth. The development of the placenta occurs at an early stage of embryogenesis. 
Here , with Pkbα -/-Pkbγ +/- mice, we observed impaired development of the skin, 
thymus and ventricle myocardium. Mice lacking PKBα and PKBγ do not survive 
beyond the mid-term and show multiple developmental defects. Therefore, PKB is 
involved in a variety of processes of embryogenesis and organogenesis.  
Placental insufficiency and embryo intrinsic mechanisms in PKBα/γ double 
knockout mice  
PKBα/γ double knockout mice are embryo lethal at around E12. The causes of death 
fall into two categories, placental insufficiency and embryo intrinsic mechanisms. 
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Previously, characterization and analysis of PKBα null mice led us to the conclusion 
that developmental abnormalities and small size of placenta restrict the growth of the 
embryo. However, we do not exclude the possibility of embryo intrinsic mechanisms 
in the control of foetal growth in the absence of PKBα. In addition, all three PKB 
proteins can be detected in wild-type placenta by Western blotting, albeit that PKBα is 
the predominant isoform. This suggests that the development of placenta is impaired 
further in PKBα/γ double knockout mice and that the double knockout embryo is in 
more unfavourable conditions. Increasing evidence has shown placental insufficiency 
to be the primary cause of embryo lethality in many knockouts, e.g. in the case of Rb 
deletion and SOCS3 inactivation (Takahashi et al., 2003; Wu et al., 2003). James Ihle 
recently wrote a review on placental defects-dependent embryo lethality in numerous 
knockout mice showing placenta as a critical determining factor for death (Ihle, 2000). 
Frequently, it is seen that foetal vascularization is not properly established in the 
labyrinth of these knockout placentas; as a result, the growth and development of the 
foetus is suppressed. Under these adverse conditions, the foetus develops abnormally 
and eventually dies (Rossant and Cross, 2001). 
The phenotypes manifested by Pkbα -/-Pkbγ +/- mice, on the other hand, strongly 
support the view that embryo intrinsic mechanisms are responsible for the embryo 
lethality. The 50% loss of PKBγ does not affect the growth of embryos and, the 
bodyweight of these mice at birth is comparable to that of single PKBα null mice. 
Nevertheless, the Pkbα -/-Pkbγ +/- mice die within 10 days of their birth and display 
developmental abnormalities of skin, thymus and heart. Because after birth the 
development, growth and remodelling of organs/tissues become independent of the 
placenta, these effects may result from the complete absence of PKBα and 50% loss of 
PKBγ. In the ventricle myocardium, there are three layers of muscles with distinct 
 119 
fibre orientations, outer spiral, middle circular and inner longitudinal. The organization 
of these muscle fibres determines the contractility of the heart. The observed alteration 
in myocardiac architecture in the ventricle of Pkbα -/-Pkbγ +/- mice suggests that these 
mice die from heart failure. This is consistent with the heart-specific deletion of PDK1 
mice (Mora et al., 2003). 
Transcriptional regulation by PKB during development 
The multiple organ/tissue defects in Pkbα -/-Pkbγ +/- mice and the embryo lethality of 
PKBα/γ double knockout mice led us to the hypothesis that certain transcription 
factors essential for development are PKB substrates or are modulated by PKB. 
Phosphorylation of these transcription factors by PKB, directly or indirectly, regulates 
their transcriptional activities and subsequent developmental events. The phenotypes 
displayed by the placenta and branchial arch arteries in PKBα/γ double knockout mice 
resemble those of Hand1(eHAND) and Hand2 (dHAND) knockout mice (Firulli et al., 
1998; Riley et al., 1998; Yamagishi et al., 2000; Yanagisawa et al., 2003). The 
appearance of Pkbα+/-Pkbγ +/- mice is similar to Twist null mice (Sosic et al., 2003). 
Hand1, Hand 2 and Twist proteins belong to the basic helix-loop-helix (bHLH) 
transcription factor family, which is involved in numerous essential developmental 
processes (Firulli et al., 1998; Riley et al., 1998; Yanagisawa et al., 2003). Recently, it 
was reported that Trachealess (Trh), a bHLH-PAS transcription factor required for 
development of the trachea and other tubular organs in Drosophila, is a new PKB/Akt 
target (Jin, et al.2001). Phosphorylation of Trh by PKB is essential for its nuclear 
localization and regulation of branching morphogenesis. In another report, it was 
suggested that PKB regulates the interaction between neural bHLH proteins and the 
CBP/p300 to promote neuronal differentiation (Vojtek, et al. 2003). More recent work 
showed that Hand proteins can be phosphorylated by PKC and PKA and that 
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phosphorylation of these proteins affects chicken development. Coincidentally, one 
phosphorylation site seems to have a PKB consensus motif (Firulli et al., 2003). 
Further work to investigate the connection between PKB proteins and bHLH in 
development is needed. 
In summary, we found that PKBα is more important than PKBγ for animal physiology 
and survival, and that both proteins are required for normal mouse development.  
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Final discussion 
The aim of the work described in this thesis was to examine the physiological and 
developmental roles of PKB/Akt proteins in mice by loss of function analysis through 
gene targeting technology. Complete knockout mice for each isoform have been 
produced, as well as mice with floxed alleles of Pkbα /Akt1 and Pkbβ /Akt2 for future 
analyses. Compound and double knockout mice of PKB/Akt were produced by 
crossing single knockout mice. Characterization of these mice has unveiled novel 
functions of PKB/Akt in development and physiology. These results will help improve 
our future understanding of these kinases. 
This thesis concerns in particular the single knockout of PKBα/Akt1 and of 
PKBγ/Akt3, and the compound knockout of PKBα/Akt1 and PKBγ/Akt3. Studies of 
PKBα/Akt and PKBγ/Akt3 mutant mice should help determine the specific role of 
these two isoforms in mice and reveal functional differences between all three 
isoforms. Analyses of PKBα/Akt1 and PKBγ/Akt3 compound and double knockout 
mice have provided insights into the role of PKB/Akt in mouse development. The 
generation and characterization of the PKBα/Akt1 mutant mouse line, as the first of its 
type in our laboratory has defined methodology and expertise that will be of use for 
studies of further mutant mice.  
I) PKB/Akt and postnatal animal survival 
The hallmark function of PKB/Akt, which has been established by experiments with 
primary cerebellar neuron cultures, is the promotion of cell survival (Brunet et al., 
1999; Datta et al., 1997; Dudek et al., 1997). Survival factors such as IGF1 can 
suppress apoptosis by activation of PKB/Akt, which subsequently phosphorylates 
BAD and forkhead transcription factors and contribute to cell survival(Brunet et al., 
1999; Datta et al., 1997; Dudek et al., 1997). Subsequent experiments using numerous 
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types of cells in a similar manner demonstrated that the IGF1/insulin/PI3K/PKB/Akt 
pathway is relevant to the survival of all cell types (Datta et al., 1999). This led to 
prediction of the early lethality with PKBα/Akt1 mutant mice, supported by the 
observation that only PKBα/Akt1 and PKBγ/Akt3 are detectable in the ES cells and 
that the PKBα/Akt1 level is markedly higher than PKBγ (Williams et al., 2000). ES 
cells are the population of inner cell mass (ICM), that together with the trophoblasts 
constitutes the very early embryo (blastocyst). If the PI3K/PKB/Akt pathway is 
indispensable for ES cell survival, deletion of PKBα should at the very least disrupt 
the growth of these cells and impair mouse development. To test this, we generated 
PKBα/Akt1 null ES cells using heterozygous ES cells. In the absence PKBα/Akt1, the 
growth of ES cells was comparable to that wild-type (data not shown). This result 
suggests that PKBγ/Akt3 alone is sufficient for cell survival or that this pathway is 
simply not essential. On the other hand, the strong potential of ES cells for 
proliferation may mean that these cells can overcome survival disadvantages. 
With PKBα/Akt1 null ES cells almost intact, it is not surprising that PKBα/Akt1 
mutant mice develop to term (Yang et al., 2003). Nevertheless, these mice do display 
increased neonatal mortality and nearly half of them die after birth (Cho et al., 2001b; 
Yang et al., 2003). Although the exact cause of death is not clear, Pkbα -/-γ +/- (Akt1-/-
3+/- ) mice provides some hints. The Pkbα -/-γ +/- (Akt1-/-3+/-) mice manifest structural 
abnormalities in thymus and heart. Previously, young PKBα/Akt1 mice were found to 
have very small thymuses (data not shown). Given that the PKBα/Akt1 level is 
normally higher than PKBγ/Akt3, the defects in Pkbα -/-γ +/- (Akt1-/-3+/- ) mice may be 
attributable mainly to PKBα/Akt1 loss (Yang et al., 2003). It is, thus, highly possible 
that the PKBα/Akt1 mutant mice die from heart failure or immune deficiency. On the 
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other hand, retarded growth of PKBα/Akt1 mutant mice, resulting from either 
placental insufficiency or an embryo intrinsic mechanism, may also impair their 
survival. This is commonly seen in humans, where the organs of pre-mature babies are 
incapable of proper function. 
Increased postnatal mortality is only seen with PKBα/Akt1 null mice; PKBγ/Akt3 null 
mice survival normally (Tschopp et al., unpublished data). There has been no 
indication of postnatal death of PKBβ/Akt2 (Cho et al., 2001a; Garofalo et al., 2003). 
Thus, of the three PKB/Akt proteins, PKBα/Akt1 displays a specific and important 
role in animal survival. Furthermore, PKB/Akt appears to play a pro-survival role not 
only in cells but also in the whole animal. Whether this is indeed related to an anti-
apoptosis effect needs further investigation. 
II) PKB/Akt and metabolism 
The pioneering demonstration of PKB/Akt activation by IGF1 and insulin greatly 
improved our understanding of the role of this kinase in metabolism and has many 
implications (Alessi et al., 1996). Both insulin and IGF1 play important roles in 
glucose, fat and protein metabolism in all human cells. In current models, the two 
growth factors/hormones trigger two main signalling pathways, Ras-Raf-MAPK and 
PI3K/PKB(Akt)/S6K. The Ras-Raf-MAPK pathway promotes mitosis and the 
PI3K/PKB(Akt)/S6K pathway regulates metabolism. 
a) Glucose metabolism. The role of PKB/Akt in glucose metabolism cannot be better 
demonstrated than in PKBβ/Akt2 null mice. In the absence of PKBβ/Akt2, mice 
develop a type 2 diabetes-like syndrome (Cho et al., 2001a; Garofalo et al., 2003). 
Insulin action is blocked in these mice, although the insulin concentration is high in 
serum (hyperinsulinemia) and glucose cannot be consumed (with consequent 
hyperglycemia) (Cho et al., 2001a; Garofalo et al., 2003). In addition,  PKBβ/Akt2-
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deficient mice exhibit glucose intolerance and impaired muscle glucose uptake (Cho et 
al., 2001a; Garofalo et al., 2003). 
It is interesting to compare insulin action and glucose metabolism in pancreatic 
PKB/Akt overexpression mice and PKBβ/Akt2-deficient mice. Both display 
hyperinsulinemia but glucose levels are normal and all three PKB/Akt proteins are 
intact in the transgenic mice (Bernal-Mizrachi et al., 2001; Cho et al., 2001a; Garofalo 
et al., 2003; Tuttle et al., 2001a). Excess insulin in serum from the transgenic mice 
fails to reduce glucose levels, suggesting a mechanism to control insulin signalling. 
However, insulin signalling is disrupted in PKBβ/Akt2-deficient mice and high insulin 
levels cannot rescue the defect in this signalling pathway (Bernal-Mizrachi et al., 2001; 
Cho et al., 2001a; Garofalo et al., 2003; Tuttle et al., 2001a). 
Glucose metabolism is normal in PKBα/Akt1 mutant mice, suggesting functional 
differences between PKBα/Akt1 and PKBβ/Akt2 in this regard (Chen et al., 2001; Cho 
et al., 2001b; Yang et al., 2003). However, we found a population of trophoblasts, the 
glycogen-containing spongiotrophoblasts, are almost completely absent from 
PKBα/Akt1 mutant placenta (Yang et al., 2003). This may be evidence that 
PKBα/Akt1 is also involved in glucose metabolism. As with PKBα/Akt1 mutant mice, 
PKBγ/Akt3 mutants show normal glucose utilization. 
The mechanism of the PKB regulation of glucose metabolism is not clear, but there are 
some reasonable hypotheses. One is that, phosphorylation by PKB negatively regulates 
GSK3 activity, which is crucial for glucose metabolism. PKB was also found to 
promote glucose transport into cells via Glut4, thus facilitating glucose utilization 
(Whiteman et al., 2002). 
b) Protein synthesis. Recent reports highlight PKB/Akt regulation of protein synthesis 
through phosphorylation of TSC2 (Tuberous sclerosis complex 2) (Gao et al., 2002; 
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Inoki et al., 2002; Potter et al., 2002). mTOR (mammalian target of rapamycin) is 
regarded as a central modulator of protein synthesis by activation of S6K1 (p70 
ribosomal protein S6 kinase) and inhibition of 4E-BP1( eukaryotic initiation factor 4 
binding protein1).  
mTOR activity is promoted by Rheb (Ras homologue enriched in brain), a small G 
protein like Ras. As a GTPase-activating protein (GAP), TSC2 can inactivate Rheb 
and, therefore, inhibit mTOR signalling. PKB/Akt can phosphorylate and inhibit 
TSC2, leading to activation of the mTOR signalling pathway and protein synthesis (Li 
et al., 2004). 
We measured the phosphorylation levels of TSC2 in PKBα/Akt1 mutant placenta but 
found little difference between the wild-type control and the knockout (Yang et al., 
2003). However, a reduction in phospho-TSC2 was seen in double knockout murine 
embryonic fibroblasts (MEFs) of PKBα/β (Akt1/2) (Peng et al., 2003). 
The elucidation of how the PKB/Akt-TSC2-Rheb-mTOR-S6K pathway controls 
protein synthesis should help answer the question of how PKB/Akt promotes cell 
growth (increase in cell size). 
c) Fat metabolism. In humans, glucose is utilized for three main purposes: the 
production of ATP as energy, fat synthesis and glycogen synthesis. Th fat in 
adipocytes and the glycogen in hepatocytes and myocytes are source of stored energy. 
Therefore, it is not surprising that PKB/Akt increased lipid synthesis as seen in the 
transgenic mice with PKB/Akt overexpression in the mammary gland (Schwertfeger et 
al., 2003). 
We found reduced subcutaneous fat in PKBα/Akt1 mutant mice (Yang et al., 2003) 
and age-dependent loss of adipose tissue is prominent in PKBα/Akt2 mutant mice 
(Garofalo et al., 2003). 
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To summarize, PKB/Akt is involved in the metabolism of the three major nutrients, 
glucose, protein and fat. The functions of PKB/Akt proteins are thus important for 
homeostasis of metabolism and critical for survival. 
III) PKB/Akt and development 
PKB/Akt not only plays a central role in metabolism but also has an impact on 
development. Alterations in mice lacking different PKB/Akt isoforms indicate that 
PKB/Akt is indispensable for normal animal development. For example, the most 
prominent phenotype displayed by PKBα/Akt1 and PKBα/β (Akt1/2) mutant mice is 
short stature (Chen et al., 2001; Cho et al., 2001b; Peng et al., 2003). PKBα/Akt1 
mutant mice also have an abnormal placental structure and the brain of PKBγ/Akt3 
mutants are smaller than wild-type (Yang et al., 2003; Tschopp et al., unpublished 
data). PKBβ/Akt2 mutant mice display age-dependent loss of adipose tissues and 
mildly reduced body size (Garofalo et al., 2003).  
Mice lacking PKBα/β (Akt1/2) show impaired skin development, atrophic skeletal 
muscle and abnormal bone development. Adipogenesis is also affected (Peng et al., 
2003). PKBα/γ (Akt1/3) double knockout mice are embryo lethal with developmental 
defects in placenta, branchial arch and arteries, and in the brain. Pkbα -/-γ +/- (Akt1-/-3+/-) 
mice die at an early age and have multiple pathology of skin, heart and thymus. 
IV) Control of size and adipogenesis by PKB/Akt: coupling of metabolism and 
development 
An intriguing question that has puzzled researchers for many years is how metabolism 
affects development. For example, when Drosophila grow under nutrient-limitated 
conditions, adults are smaller than well-fed controls (Kramer et al., 2003).  
Organism size is determined by both cell number and cell size (Conlon and Raff, 
1999). Cell size or cell growth is dependent on protein synthesis, which is regulated by 
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PKB/Akt, as discussed above. Several transgenic mouse models have confirmed 
PKB/Akt function in cell size regulation. For example, overexpression of PKB/Akt in 
cardiac myocytes, lymphocytes and pancreatic β cells increased cell size, giving rise to 
heart, thymus and islets larger than inwild-type controls (Condorelli et al., 2002; 
Malstrom et al., 2001; Matsui et al., 2002; Shioi et al., 2002). Thus, PKB/Akt is 
involved in organ growth via regulation of protein metabolism, i.e. PKB/Akt integrates 
metabolism with development.  
PKB/Akt plays a central role in glucose and fat metabolism. Overexpression of 
PKB/Akt in the mammary gland increases lipid synthesis (Schwertfeger et al., 2003). 
Deletion of PKBα, PKBβ or both impairs adipose tissue development (Garofalo et al., 
2003; Peng et al., 2003; Yang et al., 2003). In PKBα/β (Akt1/2) double knockout 
MEFs, the transcription of PPARγ, a master gene in regulating fat synthesis cannot be 
induced properly (Peng et al., 2003). These observations indicate that in the absence of 
PKB/Akt, lipid synthesis is affected; and as a result, the adipose tissue cannot develop 
normally.  
Therefore, through regulation of glucose, fat and protein metabolism, PKB/Akt 
modulates developmental events such as size control and adipogenesis. PKB/Akt 
couples metabolism with development. 
V) PKB and the cell cycle  
PKB/Akt affects not only cell growth but also cell number (cell proliferation) by 
promoting cell cycle progression. PKB/Akt facilitates G1/S transition and the initiation 
of M phase. Two important substrates of PKB/Akt, FOXO and MDM2 are involved in 
the G1/S transition. FOXO enhances transcription of p27 and downregulates cyclin D 
mRNA levels (Collado et al., 2000; Medema et al., 2000; Schmidt et al., 2002). 
Inhibition of CDK2 by p27 and decreased cyclin D levels prohibits cell cycle 
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progression iN G1. Phosphorylation of FOXO by PKB/Akt promotes its cytoplasmic 
translocation, resulting in decreased p27 transcription and increased cyclin D levels 
(Collado et al., 2000; Medema et al., 2000; Schmidt et al., 2002). Once phosphorylated 
by PKB/Akt, MDM2 moves to the nucleus and promotes p53 degradation. Induction of 
p21 transcription by p53 is reduced and the inhibition of the cell cycle in G1 by p21 is 
released (Ashcroft et al., 2002; Mayo and Donner, 2001; Ogawara et al., 2002; Zhou et 
al., 2001). Phosphorylation of GSK3 by PKB/Akt also increases cyclin D levels for the 
G1/S transition (Diehl et al., 1998).  
Phosphorylation of CHFR and Myt1 by PKB/Akt initiates M phase (Okumura et al., 
2002; Shtivelman, 2003; Shtivelman et al., 2002). 
VI) PKB/Akt and neural crest cell development.  
In E12.5 embryos, levels of PKBα/γ (Akt1/3) are particularly high in the brain and a 
variety of ganglia. Thus, PKBα/γ (Akt1/3) appear to be markers of the central and 
peripheral nervous systems. If it is true that ‘where it exists, there it functions’, these 
two PKB isoforms may play important roles in the nervous system. As ganglia 
originate from neural crest cells, there may be some relation between these proteins 
and neural crest cells, perhaps in connection with their development. In the PKBα/γ 
(Akt1/3) double knockout embryos, we found hypoplastic branchial arches and 
abnormal branchial arch arteries at around E11. At this stage, the majority of the cells 
comprising branchial arches are mesenchymal cells that are derived from neural crest 
cells. We also found alterations in Pkbα -/-γ +/- (Akt1-/-3+/-) mice of other neural crest 
derivatives, such as thymus and heart septum. All these changes indicate PKB/Akt 
involvement in neural crest cell development. To test this possibility further, it would 
be interesting to follow the migration of neural crest cells in PKBα/γ (Akt1/3) mutant 
mice during early development using various markers, or to culture neural crest cells 
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for induction of differentiation. The elucidation of PKB/Akt function here would help 
understand the formation of specific tissues. 
VII) PKB/Akt and the cardiovascular system.  
Our finding of reduced vascularisation in PKBα/Akt1 and PKBα/γ (Akt1/3) double 
mutant placentas, together with the developmental defects observed in PKBα/γ 
(Akt1/3) double mutant branchial arch arteries suggest that PKB/Akt regulates 
vascular structure (angiogenesis and vascularisation). In addition, the malformation of 
ventricle myocardium in Pkbα -/-γ +/- (Akt1-/-3+/-) mice suggests that PKB/Akt 
modulates heart development; abnormal PKB/Akt signalling may contribute to heart 
failure. Detailed study of hearts in PKBα/γ (Akt1/3) double mutant embryos could 
unveil the underlying regulatory mechanisms.  
VIII) PKB/Akt mice and tumour formation. PKB/Akt promotes cell cycle 
progression and cell growth. Therefore, it is not difficult to imagine why increased 
PKB/Akt activity gives rise to tumour formation. Angiogenesis (nes vessel formation) 
is critical for tumour development, and PKB/Akt may also contribute to tumour 
development through stimulation of novel vessel development. In the pharmaceutical 
industry, much effort is expended in a search for PKB/Akt inhibitors and, thus, for 
tumour growth inhibitors. However, our observations of PKBβ/Akt2 mice suggest that 
inhibition of tumour growth could be at the expense of changes in regulation leading to 
diabetes?  
Thus, a more detailed molecular understanding of the PKB/Akt promotion of  tumour 
formation and growth is needed for improved drug targeting. In this regard, single 
knockout mice of PKB/Akt proteins could be examined for for xenograft growth after 
tumour cell injection to see how tumour development is disrupted in the absence of 
PKB/Akt. 
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Appendix 1 
 
Early characterization of PKBα/Akt1 null ES cells, MEFs and mice 
1. Generation of Pkbα knockout ES cells 
At high concentration of G418, heterozygous ES cells of Pkbα were converted into 
homozygous ES cells. The ES clones were first characterized by Southern bloting 
with 2 different probes [Fig. 1A1) and 2)]. Western blotting using a PKBα specific 
antibody confirmed the absence of the protein [Fig. 1A3)]. Preliminary studies 
showed that the knockout ES cells grew comparably to wild-type (Fig. 1B) 
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Fig. 1. Generation of PKBα null ES cells. A.1 and 2) Southern blotting analysis of the 
two ES mutants of 15a and 15b. 3) Western blotting confirms the absence of PKBα. B. 1) 
wild-type ES cells and 2) mutant ES cells. 
However, there seems to be some difference between wild-type and the mutant ES 
cells in early embryoid body formation (Fig. 2). In the mutants, there are some 
detached cells which are rare in the wild-type. 
 
 
 
 
 
 
 
                 Fig. 2 Growth of wild-type and PKBα null embryoid body. 
2. Early characterization of PKBα mutant mice 
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Fig. 3 .Early characterization of PKBα mutant placentas and embryos. A. a litter of 
newborns from Pkbα+/- intercross. Note that the mutant mice are smaller than their 
littermates. B. RT-PCR analysis of E14 placentas and embryos. There is no up-regulation 
of these two genes in mutant placentas and embryos. C. There is no up-regulation of 
PKBβ and γ proteins shown by Western blotting. However, the level of phospho-PKB in 
mutant placenta is significantly reduced. 
3. PKBα null murine embryonic fibroblasts (MEFs) 
We generated MEFs from PKBα mutant embryos. We found that after several 
passages of culture, the mutant cells grew slower that wild-type and showed 
morphology of senescence (Fig.4B). In addition, the mutant cells are sensitive to 
UV irradiation. 
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We also designed specific oligos to knock down the the three PKB isoforms in 
wild-type MEFs (with help from Maja Hemmings). Figure 4 A shows that PKBα 
can be efficiently knocked down. 
Appendix 2 
PKBα is dispensable for lymphocyte development 
In collaboration with prof. Antonius Rolink of Department of Immunology, University 
of Basel-Pharmacen 
 
PKBα expression is abundant in thymus and spleen 
PKBα protein levels were examined in several tissues from wildtype mice by Western 
blot using an isoform-specific antibody (figure 1). Three adult mice were analysed and 
gave similar results. Compared with the other tissues, thymus and spleen have 
relatively higher levels of PKBα. In addition, it was found that the expression of 
PKBα is more abundant in thymus than in spleen, which was confirmed by 
quantitative PCR (data not shown). 
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    Fig.1 PKBα is abundant in thymus and spleen. A. Tissue distribution of PKBα shown by  
    Western blot. B. Phospho-PKB level is reduced in PKBα mutant thymus. 
Pkbα -/- mice have reduced peripheral lymphocytes 
We studied PKBα deficient mice for its function in maintain lymphocyte development.  
Two months old wild-type and Pkbα -/- mice (each genotype including 3 males and 3 
females) were sacrificed for blood collection. Hematological analysis showed that the 
total white blood cell number in peripheral blood was reduced in the Pkbα -/- mice 
(wild type, 8.1± 1.7 x 103/mm3 and Pkbα-/-, 4.98±0.95 x 103/mm3. P<0.01. Pkbα -/-
/wild type=61%. Table1). Further analysis indicates that this reduction resulted from 
the decreased lymphocytes (wild-type, 6.94±1.68 x 103/mm3 and Pkbα -/-, 3.74±0.84 x 
103/mm3. P<0.05. Pkbα -/-/wild type=54%. Table 1). Thus, peripheral lymphocytes in 
Pkbα  -/- mice were reduced. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lymphocyte development is normal in Pkbα -/- mice 
The reduced peripheral lymphocytes suggested that the development of lymphocytes is 
abnormal.  To test this, mice of 2 weeks, 4 weeks and 8 weeks old were sacrificed for 
dissection of thymus, spleen, bone marrow and lympho-node. Single cell suspensions 
were prepared from these lymphoid tissues for flow cytometry using a wide series of 
cell-specific markers, such as B220, CD19, IgM, IgD, CD4, CD8, H57, CD62, CD23, 
Table 1. Peripheral blood parameters of wild type and Pkbα-/- mice 
wild type Pkbα-/-
Total WBC
( x103/mm3)
Lymphocytes
( x103/mm3)
P value
8.18± 1.70 4.98± 0.95
6.94± 1.68 3.74± 0.84
<0.01
<0.05
In each group, 6 mice (3 males and 3 females) of 2 months were analyzed. 
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493, CD21, γ1δ, NK1, CD3, CD25, CD44, c-kit, TAC. Cells isolated from spleen and 
bone marrow were analysed  for B cell development and cells from thymus for T cell 
status. The presence of both T, B cells at different stages in lymphonode were also 
examined. The data indicated the existence of T, B cells of various developmental 
stages in Pkbα -/- mice. The relative ratios of these cells are comparable between wild 
type and Pkbα -/- mice. In vitro proliferation of mutant lymphocytes is also normal 
(Fig. 2). 
 
 
 
 
 
 
 
 
 
 
                                             Fig. 2. In vitro proliferation assay. 
 
Decreased phosphorylation of total PKB and GSK3 in Pkbα -/- thymus 
We examined the phosphorylation levels of PKB in wild type and mutant thymus by 
use of an antibody which recognizes all three phosphorylated isoforms. Thymus 
lacking PKBα displayed significant reduction of total phosphorylated PKB compared 
with wild type. In addition, we found that the phosphorylation of GSK3, one of the 
best recognized substrates, decreased greatly. This indicated that loss of 
PKBαsubstantially changed total PKB activity in thymus (Fig.1). 
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